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Abstract Complete and robust human genome duplication requires loading minichromosome
maintenance (MCM) helicase complexes at many DNA replication origins, an essential process
termed origin licensing. Licensing is restricted to G1 phase of the cell cycle, but G1 length varies
widely among cell types. Using quantitative single-cell analyses, we found that pluripotent stem
cells with naturally short G1 phases load MCM much faster than their isogenic differentiated
counterparts with long G1 phases. During the earliest stages of differentiation toward all lineages,
MCM loading slows concurrently with G1 lengthening, revealing developmental control of MCM
loading. In contrast, ectopic Cyclin E overproduction uncouples short G1 from fast MCM loading.
Rapid licensing in stem cells is caused by accumulation of the MCM loading protein, Cdt1.
Prematurely slowing MCM loading in pluripotent cells not only lengthens G1 but also accelerates
differentiation. Thus, rapid origin licensing is an intrinsic characteristic of stem cells that contributes
to pluripotency maintenance.
DOI: https://doi.org/10.7554/eLife.30473.001
Introduction
Metazoan DNA replication requires initiation at thousands of DNA replication origins during S phase
of every cell cycle. Origins are genomic loci where DNA helicases first unwind DNA and DNA synthe-
sis begins. Origins are made competent for replication during G1 phase of each cell cycle by the
loading of minichromosome maintenance (MCM) complexes onto DNA. MCM is the core compo-
nent of the replicative helicase, and the process of MCM loading is termed origin licensing. Total
MCM levels remain constant throughout the cell cycle, but the levels of DNA-loaded MCM change
as cells progress through the cell cycle. Cells can begin MCM loading as early as telophase and load-
ing continues throughout G1 until the G1/S transition, the point of maximum DNA-loaded MCM
(Kimura et al., 1994; Todorov et al., 1995). Throughout S phase, individual MCM complexes are
activated for DNA unwinding as origins ‘fire’. MCM complexes travel with replication forks and are
progressively unloaded as replication forks terminate (Figure 1a) (Deegan and Diffley, 2016;
Remus and Diffley, 2009; Siddiqui et al., 2013).
The control of origin licensing is critical for genome stability. Origins must not be re-licensed after
S phase begins because such re-licensing can cause a genotoxic phenomenon known as re-replica-
tion which may result in double strand breaks, gene amplification, aneuploidy, and general genome
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instability (Arias and Walter, 2007; Truong and Wu, 2011). To avoid re-replication, MCM loading is
tightly restricted to G1 phase by multiple overlapping mechanisms that destroy or inactivate MCM
loading proteins to prevent any new origin licensing after S phase begins (Remus and Diffley, 2009;
Arias and Walter, 2007; Truong and Wu, 2011). On the other hand, cells typically load 5- to 10-
fold more MCM complexes in G1 than they strictly require under ideal circumstances, and the addi-
tional MCM loading ensures timely and complete genome duplication even if replication hurdles are
encountered in S phase (Ibarra et al., 2008; Woodward et al., 2006; Ge et al., 2007). It is possible
for cells to proliferate with less than optimal MCM loading, but such cells are hypersensitive to DNA
damage and replication stress (Blow et al., 2011; McIntosh and Blow, 2012).
MCM loading to license origins is restricted to G1, but G1 length varies widely among different
cell types. For example, specialized developmental and immune cell cycles have minimal G1 lengths
of mere minutes (O’Farrell et al., 2004; Kinjyo et al., 2015; Kermi et al., 2017). In cultured human
embryonic stem cells, G1 is only 2–3 hr, and this short G1 is both a hallmark of and has been impli-
cated in maintaining pluripotency (Soufi and Dalton, 2016; Kareta et al., 2015a). G1 lengthens
early in differentiation, and in cultured somatic cells is often greater than 12 hr (Calder et al., 2013).
Thus, different proliferating cells have drastically different amounts of time available to complete
MCM loading before making the G1-to-S phase transition. In addition, pluripotent stem cells
respond to differentiation stimuli specifically in G1 phase, suggesting that the balance among cell
cycle phases influences differentiation potential (Gonzales et al., 2015; Pauklin and Vallier, 2013).
Given that MCM loading is restricted to G1 and the wide variation of G1 lengths, we postulated
that the absolute amount of loaded MCM in S phase is a product of both the time spent in G1 and
the rate of MCM loading. The combination of these two parameters has implications for genome
stability because loading more or less MCM in G1 influences S phase length and how effectively S
phase cells can accommodate both endogenous and exogenous sources of replication stress
(Shima et al., 2007; Pruitt et al., 2007). These implications are relevant both when cell cycle
eLife digest From red blood cells to nerve cells, animals’ bodies contain many different types of
specialized cells. These all begin as stem cells, which have the potential to divide and make more
stem cells or to specialize.
All dividing cells must first unwind their DNA so that it can be copied. To achieve this, cells load
DNA-unwinding enzymes called helicases onto their DNA during the part of the cell cycle known as
G1 phase. Cells must load enough helicase enzymes to ensure that their DNA is copied completely
and in time. Stem cells divide faster than their specialized descendants, and have a much shorter G1
phase too. Yet these cells still manage to load enough helicases to copy their DNA. Little is known
about how the amount, rate and timing of helicase loading varies between cells that divide at
different speeds.
Now Matson et al. have measured how quickly helicase enzymes are loaded onto DNA in
individual human cells, including stem cells and specialized or “differentiated” cells. Stem cells
loaded helicases rapidly to make up for the short time they spent in G1 phase, while differentiated
cells loaded the enzymes more slowly. Measuring how the loading rate changed when stem cells
were triggered to specialize showed that helicase loading slowed as the G1 phase got longer.
Matson et al. found that the levels of key proteins required for helicase loading correlated with the
rates of loading. Altering the levels of the proteins changed how quickly the enzymes were loaded
and how the cells behaved – for example, slowing down the loading of helicases made the stem
cells specialize quicker.
These findings show that the processes of cell differentiation and DNA replication are closely
linked. This study and future ones will help scientists understand what is happening during early
animal development, when specialization first takes place, as well as what has gone wrong in cancer
cells, which also divide quickly. A better understanding of this process also helps in regenerative
medicine – where one of the challenges is to make enough specialized cells to transplant into a
patient with tissue damage without those cells becoming cancerous.
DOI: https://doi.org/10.7554/eLife.30473.002
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distributions change during development and during oncogenesis since many cancer cell lines also
have short G1 phases. The actual rate of MCM loading in human cells has not yet been quantified,
however, and little is known about how the amount, rate or timing of MCM loading varies between
cells with different G1 lengths. Here, we utilized single-cell flow cytometry to measure MCM loading
rates in asynchronous populations of pluripotent and differentiated cells. We discovered that rapid
MCM loading is intrinsic to pluripotency, slows universally during differentiation, and rapid replica-
tion licensing suppresses differentiation. These findings demonstrate that the rate of MCM loading
is subject to developmental regulation, and we suggest that rapid origin licensing is a new hallmark
of pluripotency.
Figure 1. Pluripotent stem cells load MCMs faster than differentiated cells. (a) DNA-loaded MCM levels increase in G1 and decrease in S phase,
whereas total MCM protein levels are constant throughout the cell cycle. (b) Flow cytometric analysis of DNA-loaded and total MCM in asynchronously
proliferating RPE1-hTERT cells. Cell cycle phases are defined by DNA content and DNA synthesis. Left: Cells were labeled with EdU, extracted with
nonionic detergent to remove unbound MCM, fixed, and stained with anti-MCM2 (a marker for the MCM2-7 complex), DAPI (total DNA), and for EdU
incorporation (active DNA synthesis). Orange cells are S-phase with DNA-loaded MCM, blue cells are G1-phase with DNA-loaded MCM, and grey cells
are G1/G2/M phase cells without DNA-loaded MCM. Right: Cells were treated as on the left except that they were fixed prior to extraction to detect
total MCM2. (c) T98G cells were synchronized in G0 by contact inhibition and serum deprivation, then released into G1 for 10 or 12 hr, or re-
synchronized in early S with hydroxyurea (HU), and released into S for 6 or 8 hr. MCM3 in chromatin-enriched fractions (Loaded) or whole cell lysates
(Total) was detected by immunoblotting. (d) Chromatin flow cytometry of the indicated asynchronous cell lines measuring DNA content (DAPI), DNA
synthesis (EdU incorporation), and loaded MCM (anti-MCM2). Blue Cells are G1-MCMDNA-positive and EdU-negative, orange are S phase-MCMDNA-
positive; grey are G1/G2/M-MCMDNA-negative. (e) Stacked bar graph of cell cycle phase distribution from cells in (d); mean with error bars ± SD (n = 3
biological replicates). The percentage of G1 cells in each population is reported in the green sectors. The doubling times were calculated
experimentally using regression analysis in GraphPad Prism.
DOI: https://doi.org/10.7554/eLife.30473.003
The following figure supplements are available for figure 1:
Figure supplement 1. Flow cytometry gating.
DOI: https://doi.org/10.7554/eLife.30473.004
Figure supplement 2. Validation of chromatin flow cytometry.
DOI: https://doi.org/10.7554/eLife.30473.005
Figure supplement 3. Characterization of pluripotent and differentiated cells.
DOI: https://doi.org/10.7554/eLife.30473.006
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Results
Pluripotent cells load MCM significantly faster than differentiated cells
We considered two possibilities for how cells with varying G1 lengths load MCM onto DNA. One
possibility is that cells with short G1 phases load MCM at the same rate as cells with long G1 phases
resulting in less total loaded MCM. Alternatively, cells with short G1 phases could load MCM faster
than cells with long G1 phases and reach similar levels of loaded MCM. To distinguish between
these scenarios, we developed an assay to measure DNA-loaded MCM in individual cells of asyn-
chronously proliferating populations by adapting a previously reported flow cytometry method
(Ha˚land et al., 2015; Moreno et al., 2016). We extracted immortalized epithelial cells (RPE1-hTERT)
with nonionic detergent to remove soluble MCM. We then fixed the remaining chromatin-bound
proteins for immunofluorescence with anti-MCM2 antibody as a marker of the MCM2-7 complex, and
for DNA content (DAPI) and DNA synthesis (EdU) to measure cell cycle phases (Figure 1b, left). We
used a sample without primary antibody as a control (relevant flow cytometry gating schemes are
shown in Figure 1—figure supplement 1). For chromatin flow cytometry, MCM signal below the
antibody threshold is colored grey (‘G1/G2/M-MCMDNA neg’), whereas detectable MCM signal is
colored either blue in G1 cells (‘G1-MCMDNA pos’) or orange in S phase cells (‘S-MCMDNA pos’). As
expected, total MCM protein levels do not substantially change during the cell cycle (Figure 1b,
right) (Todorov et al., 1995). For comparison to commonly used cell fractionation methods to assess
MCM dynamics, we also probed immunoblots of chromatin-enriched fractions, and noted a similar
MCM expression, G1 loading, and S phase unloading pattern (Figure 1c) (Cook et al., 2002;
Me´ndez and Stillman, 2000). Interestingly, individual G1 cells (blue stripe) have a very broad range
of DNA-loaded MCM levels with a more than 100-fold difference between minimum and maximum
(Figure 1b, left). MCMs are unloaded during S phase, ending in G2/M with undetectable MCM on
DNA (Figure 1b, left). Moreover, loaded MCM is resistant to extraction in high-salt buffer which
removes peripherally bound chromatin proteins (Figure 1—figure supplement 2f–h), similar to
yeast MCM complexes loaded in vitro (Bowers et al., 2004; Randell et al., 2006). We validated
MCM2 antibody specificity using quiescent G0 synchronized cells (MCM unloaded), and we also
observed the same broad G1 signal distribution using MCM3 antibody (Figure 1—figure supple-
ment 2a–d).
Loaded MCM complexes are extremely stable on DNA, both in vivo and in vitro (Cocker et al.,
1996; Evrin et al., 2009; Remus et al., 2009; Bowers et al., 2004). In human cells, MCMs can per-
sist on DNA for more than 24 hr during a cell cycle arrest and are typically only unloaded during S
phase (Kuipers et al., 2011). These properties result in MCM loading that occurs unidirectionally
throughout G1 phase (Symeonidou et al., 2013). The unidirectional nature of MCM loading means
that G1 cells with low MCM levels are in early G1, and G1 cells with high MCM levels are in late G1.
Since we observed a broad distribution of MCM loading throughout G1 including many cells with
low levels of loaded MCM, we conclude that RPE1-hTERT cells load MCM relatively slowly during
their ~ 9 hr G1.
We then used this method to analyze MCM loading in asynchronous cells with different G1
lengths. H9 human embryonic stem cells (hESCs) have a short G1 phase and spend most of the cell
cycle in S phase. In contrast to the differentiated epithelial cells, the majority (~80%) of G1 hESCs
had high levels of loaded MCM; very few G1 cells had low levels of loaded MCM (blue cells,
Figure 1d). This difference suggests that hESCs load MCM rapidly to achieve abundant DNA-loaded
MCM in a short time. To test if MCM loading varies in differentiated cells, we differentiated hESCs
into neural progenitor cells (NPCs) to generate an isogenic pair of pluripotent and differentiated
cells. In contrast to hESCs, differentiated NPCs had a longer doubling time and a wide distribution
of DNA-loaded MCM in G1 (blue cells, Figure 1d); they also spend approximately five time longer
in G1 (Figure 1e; e.g. 15% of a 17 hr hESC cell cycle is 2.5 hr in G1 vs 45% of a 30 hr NPC cell cycle
is 13.6 hr in G1). Since the NPCs had many cells with low levels of DNA-loaded MCM, we conclude
that these differentiated cells load MCM more slowly than hESCs.
To generate another isogenic pair of pluripotent and differentiated cells, we reprogramed ARPE-
19 primary retinal pigmented epithelial cells (RPE) into induced pluripotent stem cells (iPSCs). The
iPSCs had hallmark features of pluripotency as measured by microscopy, bisulfite sequencing, gene
expression, and teratoma formation (Figure 1—figure supplement 3), and their G1 phases were
typically seven times shorter than their differentiated parents (Figure 1e). Like hESCs, the
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pluripotent iPSCs had predominantly high levels of DNA-loaded MCM in G1 (Figure 1d). Impor-
tantly, both of the pluripotent cell lines reached approximately equal levels of DNA-loaded MCM at
the start of S phase as their differentiated counterparts did, but in in less time (the absolute MCM
loading intensities are comparable when samples are processed and analyzed with identical instru-
ment settings). Taken together, these data demonstrate that pluripotent cells load MCMs rapidly in
G1, but differentiated cells load MCMs slowly.
We then quantified the relative MCM loading rates in pluripotent and differentiated cells using
ergodic rate analysis, a mathematical method that can derive rates from fixed, steady state popula-
tions (Kafri et al., 2013). Ergodic analysis can measure any unidirectional rate parameter from a
steady state distribution and is not limited to the cell cycle (e.g. car traffic jams) (Gray and Griffeath,
2001). The ergodic analysis as applied to the cell cycle means that within a steady state population
with a constant doubling time and cell cycle distribution, the number of cells at any point in the cell
cycle is inversely related to the rate they move through that point. For any measured parameter, the
density of cells indicates rate: low cell density on a flow cytometry plot indicates a fast rate passing
through that cell cycle state, whereas high cell density indicates a slow rate. This phenomenon is
analogous to a high density of slow-moving cars observed at a given point on a road in a traffic jam
compared to a low density of fast-moving cars on an open highway. We visualized MCM loading as
histograms of the MCMDNA intensities in only the G1 cells for ergodic rate analysis (G1-MCMDNA,
Figure 2a,b and Figure 2—figure supplement 1).
To compute MCM loading rate per hour, we experimentally determined the cell cycle distribu-
tions and doubling times of each cell population (Figure 2—figure supplement 1). Pluripotent cells
reached near equal levels of loaded MCM at the G1/S transition in less time than differentiated cells.
To quantify the actual MCM loading rate difference, we subdivided the G1-MCMDNA population
into 10 equally-sized bins, calculated the MCM loading rate for each bin, then the overall average
MCM loading rate for each G1 population. These calculations revealed that pluripotent hESCs
loaded MCM 6.5 times faster per hour than differentiated NPCs and pluripotent iPSCs loaded MCM
3.9 times faster per hour than differentiated RPEs (Figure 2c). Thus, pluripotent cells with short G1
phases load MCMs significantly faster than differentiated cells with long G1 phases.
Figure 2. Quantification of MCM loading rate by ergodic rate analysis. (a) Gating scheme for chromatin flow cytometry of iPSCs measuring DNA
content (DAPI), DNA synthesis (EdU incorporation), and loaded MCM (anti-MCM2); this sample is from Figure 1d. (b) Histograms of only the G1-
MCMDNA-positive cells from the four chromatin flow cytometry samples in Figure 1d. (c) Calculated mean MCM loading rate per hour by ergodic rate
analysis; mean with error bars ± SD. (n = 3 biological replicates), unpaired two tailed t-test. **p=0.0049. ***p=0.001. See Materials and methods for
details. See also Figure 2—source data 1.
DOI: https://doi.org/10.7554/eLife.30473.007
The following source data and figure supplement are available for figure 2:
Source data 1. Raw ERA values.
DOI: https://doi.org/10.7554/eLife.30473.009
Figure supplement 1. Ergodic rate analysis binning.
DOI: https://doi.org/10.7554/eLife.30473.008
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Differentiation, G1 length, and MCM loading rate are coupled
We hypothesized that MCM loading is fundamentally linked to pluripotency because MCM loading
rate decreased during differentiation and increased during reprogramming. This idea predicts that
slowed MCM loading is a phenomenon common to differentiation towards all germ layers. To test
that hypothesis, we initiated differentiation in hESCs toward the three embryonic germ layers (neuro-
ectoderm, mesoderm and endoderm), collecting cells at 24 hr and 48 hr after inducing differentia-
tion (Figure 3—figure supplement 1). We confirmed progress toward each lineage by the expected
gene expression changes, particularly induction of lineage-specific markers and modest reduction of
pluripotency markers – even at these very early time points (Figure 3c). We assessed MCM loading
rates during differentiation by flow cytometry as before. The MCM loading rate clearly decreased
for all germ layers rapidly within the first 48 hr of initiating differentiation (Figure 3a, compare the
grey histograms for undifferentiated G1 cells to the green and blue histograms). The decrease in
MCM loading rate also coincided with the increase in the proportion of G1 cells for each lineage.
For example, within 24 hr of neuroectoderm differentiation, G1 had already lengthened and MCM
loading had slowed, but during mesoderm (BMP4) differentiation both G1 lengthening and slowed
MCM loading took 48 hr (Figure 3a and b). The closely coordinated changes that we universally
observed during differentiation suggest that MCM loading rate is coupled to G1 length. Importantly,
these results demonstrate that the rate of origin licensing by MCM loading is developmentally
regulated.
We next asked if G1 length and MCM loading rate are obligatorily coupled, or if the link can be
short-circuited by artificially advancing the G1/S transition. To distinguish between these possibili-
ties, we constructed an RPE1-hTERT derivative with a CYCLIN E1 cDNA under doxycycline-inducible
control. Cyclin E1 overproduction reproducibly shortened G1 length, consistent with previous stud-
ies (Figure 4a,b) (Resnitzky et al., 1994; Ekholm-Reed et al., 2004). Strikingly, cells overproducing
Cyclin E1 (designated as ‘"Cyclin E1’) not only spent less time in G1 but also began S phase with
much lower amounts of loaded MCM compared to the control; this new subpopulation appeared in
the central triangular region of the plots that is typically clear of S phase cells (Figure 4c,d orange
S-MCMDNApos). Cyclin E1 overproduction dramatically increased the proportion of these MCM-low
early S phase cells by sixfold from 9.9% of control S phase cells to 63.6% of "Cyclin E1, S phase cells
(Figure 4c-e). We also conclude that the MCM loading rate did not increase to accommodate the
shorter G1 because the MCM loading pattern in G1 remained constant and the "Cyclin E1 cells had
on average at least two-fold less DNA-loaded MCM in early S phase than control cells (Figure 4f–h).
Furthermore, the "Cyclin E, MCM-low cells incorporated significantly less EdU per unit time than
MCM-high cells did (1.6 fold lower mean, 1.8 fold lower median), indicating that low levels of loaded
MCM are insufficient for normal S phase progression (Figure 4i). The early S phase cells with the
least MCM loaded also had the least DNA synthesis by EdU intensity (data not shown). Thus, short-
ening G1 length without increasing MCM loading rate causes G1 cells to enter S phase prematurely
without the full complement of DNA-loaded MCM.
Previous studies have shown that CDKs can inhibit MCM loading by directly inhibiting MCM load-
ing factors, such as by stimulating Cdt1 degradation (Cdc10-dependent transcript 1), a protein
essential for MCM loading (Ekholm-Reed et al., 2004; Sugimoto et al., 2004; Tanaka and Diffley,
2002). Cdt1 levels in lysates of asynchronous cells indeed decreased upon Cyclin E1 overproduction
(Figure 4—figure supplement 1a). On the other hand, since Cdt1 is stable in G1 phase and
degraded in S phase, the lower Cdt1 signal could have reflected less Cdt1 in the lysate due to the
higher proportion of S phase cells; this indirect effect could apply to any cell cycle-regulated protein
in cell populations with different cell cycle distributions. To test that idea, we measured total Cdt1
protein levels specifically in G1 by flow cytometry (Figure 4—figure supplement 1b). Cyclin E over-
production did not significantly reduce Cdt1 G1 levels relative to control (1.1-fold higher mean, 1.2
higher median, Figure 4—figure supplement 1c). We validated the Cdt1 antibody for immunofluo-
rescence flow cytometry (Figure 4—figure supplement 1d–f). We conclude that Cyclin E/Cdk2
inhibits MCM loading indirectly, at least in part, by shortening G1 and decreasing the time available
for MCM loading.
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Fast loading hESCs have more Cdt1 in G1
Loading MCM complexes onto DNA requires the six subunit Origin Recognition Complex (ORC),
Cdc6, and Cdt1. We hypothesized that fast MCM loading in pluripotent stem cells is achieved by
increased levels of the loading proteins. To test this idea, we probed protein lysates of asynchronous
cells to compare the amount of MCM loading proteins between isogenic cell lines. Total Mcm2 and
ORC protein levels remained constant (Figure 5a). The other MCM loading factors normally change
in their abundance during the cell cycle due to regulated proteolysis. Cdc6 protein levels are low in
G1 and high in S phase (Figure 5b). Conversely, Cdt1 protein levels are high in G1 and low in S
phase (Figure 5b) (Mailand and Diffley, 2005; Pozo and Cook, 2016). Since an asynchronous
Figure 3. Differentiation universally decreases MCM loading rate. (a) Chromatin flow cytometry of hESCs induced
to differentiate toward mesoderm (BMP4), neuroectoderm, mesoderm (GSK3bi), or endoderm for 24 or 48 hr.
Histograms show only G1-MCMDNA cells positive as in Figure 2b. See methods for differentiation protocols. Cell
counts for 24 hr and 48 hr were normalized relative to corresponding hESC samples. (b) Stacked bar graphs of cell
cycle distribution for cells in (a). (c) Gene expression analysis of differentiation markers by quantitative PCR of the
samples in (a); log2 expression is relative to the undifferentiated cells. Data are mean ±SD of two biological
replicates.
DOI: https://doi.org/10.7554/eLife.30473.010
The following figure supplement is available for figure 3:
Figure supplement 1. Stem cell differentiation.
DOI: https://doi.org/10.7554/eLife.30473.011
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population of pluripotent cells spends significantly more time in S phase than differentiated cells do,
we expected Cdc6 levels to be higher in asynchronous pluripotent cells compared to their isogenic
counterparts. Cdc6 was indeed higher in pluripotent cells, as was Geminin, a protein regulated in a
similar manner as Cdc6 (Figure 5a) (McGarry and Kirschner, 1998). To our surprise, even though
the majority of asynchronous pluripotent cells were in S phase, a time when Cdt1 is degraded, Cdt1
levels were higher in asynchronous pluripotent cells than in isogenic differentiated cells (Figure 5a).
A similar observation was reported for mouse embryonic stem cells (Ballabeni et al., 2011). These
data imply that Cdt1 levels are higher in G1 phase of pluripotent cells than G1 of differentiated cells,
providing a potential explanation for fast MCM loading in pluripotent cells.
To directly measure Cdt1 levels specifically in G1, we collected asynchronous hESCs and NPCs
then fixed and stained them for Cdt1, EdU and DAPI. S phase Cdt1 degradation in hESCs is similar
Figure 4. Cyclin E overproduction uncouples MCM loading and G1 length. (a) Immunoblots of a stable derivative of RPE1-hTert cells bearing an
integrated doxycycline-inducible cyclin E construct treated with 100 ng/mL doxycycline for 72 hr to overproduce Cyclin E1 ("Cyclin E1) or with vehicle
control. (b) Stacked bar graphs of cell cycle distribution measured by flow cytometry for cells shown in (a); mean with error bars ± SD (n = 3 biological
replicates). (c) Chromatin flow cytometry of control or cyclin E-overproducing cells measuring DNA content (DAPI), DNA synthesis (EdU incorporation),
and loaded MCM (anti-MCM2). (d) S phase-MCMDNA-positive cells from samples in (c) divided into populations that began S phase with high or low
MCMDNA. Early S cells are S phase cells with G1 DNA content. (e) The percentage of MCMDNA positive, but-low MCM signal intensity S phase cells out
of all S-MCMDNA-positive cells from three biological replicates; mean with error bars ± SD, unpaired two tailed t-test. ***p=0.002. (f) Mean loaded
MCM in early S phase, (S-MCMDNA positive, G1 DNA content) from three biological replicates; mean with error bars ± SD, unpaired two tailed t-test.
***p=0.0004. (g) Histogram of G1-MCMDNA-positive cells from samples shown in (c). Counts for "Cyclin E1 are normalized to the control. (h) Histogram
of early S cells from samples shown in (d). Counts for "Cyclin E1 are normalized to the control. (These data are one of the replicates quantified in (f).). (i)
EdU intensity from "Cyclin E1, MCM-high or MCM-low cells from (d) as box-and-whiskers plots. Center line is median, outer box edges are 25th and
75th percentile, whiskers edges are 1st and 99th percentile, individual data points are lowest and highest 1%, respectively. Median EdU incorporation of
MCM-high "Cyclin E1 cells is 1.8 fold greater than MCM-low, mean EdU incorporation is 1.6-fold greater in MCM-high than MCM-low, average of three
biological replicates. Samples compared by unpaired, two tailed t-test, **p=0.0027, **p=0.0033, respectively.
DOI: https://doi.org/10.7554/eLife.30473.012
The following figure supplement is available for figure 4:
Figure supplement 1. G1 Cdt1 levels are unaffected by Cyclin E overproduction.
DOI: https://doi.org/10.7554/eLife.30473.013
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to differentiated cells with very low levels in S phase (purple, Figure 5c). In contrast, the hESCs had
a large population of cells with high Cdt1 levels in G1 (green cells) and significant amounts of Cdt1
in G2/M phase (grey cells), whereas the NPCs had a broad and overall lower Cdt1 distribution in G1
and very little Cdt1 in G2/M (Figure 5d). The G1 hESCs consistently harbored significantly more
Cdt1 than G1 NPCs did (2.9-fold higher median, 2.2-fold higher mean, three replicates [Figure 5d]).
We note that CDT1 mRNA is modestly but consistently higher in asynchronous hESCs compared to
differentiated derivatives, and that Cdt1 protein levels decrease during early differentiation coinci-
dent with the slowdown in licensing rate, but before loss of Oct4 (Figure 3c and Figure 3—figure
supplement 1). We postulate that the higher amount of this essential MCM loading protein specifi-
cally in G1 contributes to the fast MCM loading rate in hESCs.
Manipulating MCM loading factors alters MCM loading rates
Cdt1 is essential for MCM loading (Pozo and Cook, 2016); therefore, reducing Cdt1 levels should
slow MCM loading. If MCM loading rate is linked to G1 length, then slowing MCM loading by reduc-
ing Cdt1 levels could also lengthen G1. To test this prediction, we used siRNA to reduce Cdt1 in
Figure 5. hESCs have high levels of Cdt1 in G1. (a) Immunoblots of whole cell lysates from the indicated
asynchronous cell lines. (b) Expected changes in total protein levels of Cdt1 and Cdc6 during the human cell cycle.
(c) Total Cdt1 detected in asynchronous cells by flow cytometry measuring DNA content (DAPI), DNA synthesis
(EdU incorporation), and Cdt1 (anti-Cdt1). Green cells are G1, purple cells are S phase (EdU positive), grey cells
are G2/M. (d) Box-and-whiskers plots of G1 Cdt1 concentration per cell from (C). Center line is median, outer box
edges are 25th and 75th percentile, whiskers edges are 1st and 99th percentile, individual data points are lowest
and highest 1%, respectively. Median G1 Cdt1 in hESCs is 2.9-fold greater, mean is 2.2-fold greater than G1 Cdt1
in NPCs, mean p=0.0504 median p=0.0243, average of three biological replicates. Flow plots are G1 cells only
(green) from (c).
DOI: https://doi.org/10.7554/eLife.30473.014
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hESCs and measured changes in both MCM loading rate and G1 length (Figure 6a,b). As expected,
Cdt1 depletion reduced MCM loading rate in hESCs (Figure 6c). Strikingly, G1 length increased
coincidentally with the decrease in MCM loading rate (Figure 6d). These data corroborate the close
link between MCM loading rate and G1 length in hESCs.
As a complement to slowing MCM loading in hESCs with a short G1, we also attempted to accel-
erate origin licensing in cells with a long G1 by overproducing essential licensing proteins. We first
constructed an RPE_hTERT derivative with ~two-fold inducible Cdt1 overproduction, but this manip-
ulation was insufficient to accelerate MCM loading (Figure 6—figure supplement 1b). We also
tested ectopic myc-tagged Cdc6 expressed constitutively in RPE cells (Figure 6e); this addition also
had only minimal effects on MCM loading rate (Figure 6g, compare the grey and green histograms).
We considered, however, that human Cdc6 is unstable throughout much of G1 phase because it is
targeted for degradation by APCCdh1 Mailand and Diffley, 2005; Petersen et al., 2000. We there-
fore expressed a previously-described Cdc6 mutant that is resistant to APCCDH1-mediated destruc-
tion both alone and combination with inducible Cdt1 (Figure 6e and Figure 6—figure supplement
1a) (Mailand and Diffley, 2005; Petersen et al., 2000). We have previously demonstrated that
tagged Cdc6 and Cdt1 are functional (Cook et al., 2002; Coleman et al., 2015;
Chandrasekaran et al., 2011). Expression of the stable Cdc6-mut was sufficient to increase MCM
loading rates (Figure 6g, compare the blue histogram to the grey and green histograms); Cdt1 over-
production had little additive effect on MCM loading rate in RPE cells (Figure 6—figure supplement
1b). Interestingly accelerating MCM loading by this method did not shorten G1 in RPEs (Figure 6f),
further demonstrating that the length of G1 phase and the rate of MCM loading to license origins
can be uncoupled. Slow MCM loading may delay S phase entry through the licensing checkpoint
Figure 6. Manipulating MCM loading factors alters MCM loading rates. (a) Chromatin flow cytometry for hESCs treated with 25 nM siCdt1 or 100 nM
siControl for 24 hr and labeled with EdU for 30 min prior to harvest. (b) Immunoblot of total protein from cells in (a). (c) Stacked bar graph of cell cycle
distributions for samples in (a); representative of two biological replicates. The percentage of G1 cells in each population is reported in the green
sectors. (d) Histograms of loaded MCM in G1-MCMDNA cells. Counts for siCdt1 are normalized to the corresponding siControl sample. (e) Immunoblots
of Cdt1 and Cdc6 in RPE cells with combinations of the following: constitutive production of 5Myc-Cdc6-wt or 5myc-Cdc6-mut (not targeted for
degradation by APCCDH1: R56A, L59A, K81A, E82A, N83A) and an integrated doxycycline-inducible Cdt1-HA construct treated with 100 ng/mL
doxycycline for 48 hr to overproduce Cdt1-HA. (f) Stacked bar graphs of cell cycle distribution measured by flow cytometry for cells shown in (e); mean
with error bars ± SD (n = 3 biological replicates). The percentage of G1 cells in each population is reported in the green sectors. (g) Histogram of
loaded MCM in G1-MCMDNA-positive cells from (e). Counts of Cdc6-wt and Cdc6-mut are normalized to parent RPE controls.
DOI: https://doi.org/10.7554/eLife.30473.015
The following figure supplement is available for figure 6:
Figure supplement 1. Manipulating MCM loading factors alters MCM loading rates.
DOI: https://doi.org/10.7554/eLife.30473.016
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(Teer et al., 2006; Shreeram et al., 2002; Nevis et al., 2009; Ge and Blow, 2009), but rapid MCM
loading itself is not sufficient to trigger S phase entry.
Rapid MCM loading protects hESC pluripotency
Our demonstration that slower MCM loading occurs universally during early differentiation sug-
gested a functional link between the rate of MCM loading and pluripotency maintenance. We con-
sidered that slowing MCM loading might promote differentiation. To explore this idea, we
prematurely slowed MCM loading in hESCs by Cdt1 depletion prior to inducing their differentiation
(Figure 7e). After Cdt1 depletion, we stimulated differentiation toward mesoderm with BMP4
(Bernardo et al., 2011). After 48 hr, we quantified Oct4 and Cdx2 by immunostaining (Figure 7a,
Figure 7—figure supplement 1). The pluripotency transcription factor Oct4 and the homeobox
transcription factor Cdx2 reciprocally repress one another’s expression, creating a clear distinction
between Oct4-positive Cdx2-negative pluripotent cells and Oct4-negative Cdx2-positive differenti-
ating cells (Niwa et al., 2005). We quantified the mean fluorescence intensity of both Oct4 and
Cdx2 in >18,000 cells per condition with a customized, automated CellProfiler pipeline, plotting the
signal intensities for each cell in a density scatter plot (Figure 7b,c). Stimulating control hESCs with
10 ng/mL of BMP4 slightly shifted the population toward differentiation, but most cells remained
pluripotent with high Oct4 levels at this time point. Strikingly, hESCs pretreated with Cdt1 siRNA to
prematurely slow MCM loading gained a substantial population of Oct4 negative-Cdx2 positive dif-
ferentiating cells relative to controls that were treated similarly. To quantify the extent of differentia-
tion, we divided the Cdx2 intensity of each cell by its Oct4 intensity, creating a single differentiation
score (Figure 7d). After 10 ng/ml BMP4 treatment, Cdt1-depleted hESCs had significantly higher
scores, indicating that prematurely slowing MCM loading promoted differentiation (p<0.0001, two-
tailed Mann-Whitney test). Both control cells and Cdt1-depleted cells differentiated more fully at a
higher concentration of 50 ng/mL BMP4, but the Cdt1-depleted cells still differentiated further than
the controls (p<0.0001, two-tailed Mann-Whitney test, Figure 7b and Figure 7—figure supplement
2a). Other combinations of BMP4 concentrations or treatment times also resulted in a consistent,
significant increase in differentiation in cells pretreated to slow MCM loading (p<0.0001, two-tailed
Mann-Whitney test, data not shown). Importantly, the phenotype was conserved across multiple dif-
ferentiation lineages, as prematurely slowing MCM loading prior to endoderm differentiation also
increased the number of cells positive for the endoderm transcription factor Sox17 relative to con-
trols at the same time point (Figure 7—figure supplement 1b). To test if the pluripotency mainte-
nance was due to Cdt1’s role in origin licensing and not its mitotic or other functions (Varma et al.,
2012), we slowed licensing by depleting the orthogonal MCM loading protein, Cdc6 (Figure 7—fig-
ure supplement 3a–d). A more modest Cdc6 knockdown correlated with a weaker, but detectable
effect on MCM loading. Interestingly, this degree of licensing inhibition had no effect on G1 length.
Despite the short G1 length, slowing MCM loading by depleting Cdc6 significantly promoted differ-
entiation (Figure 7—figure supplement 2b–f, p<0.0001, two-tailed Mann-Whitney test. Thus, we
conclude that slow MCM loading generally promoted differentiation and by extension, that rapid
MCM loading preserves pluripotency.
Discussion
In this study, we demonstrate that rapid MCM loading to license replication origins is an intrinsic
property of pluripotent cells. Human embryonic stem cells have a remarkably fast MCM loading
rate, and reprogramming to create induced pluripotent stem cells increases MCM loading rate.
Moreover, MCM loading slows concurrently with the G1 lengthening and extensive cell cycle remod-
eling that accompany the early stages of differentiation (Figure 7f). To our knowledge, this is the
first demonstration that the rate of MCM loading is developmentally regulated. Developmental reg-
ulation of MCM loading rate is consistent with previous work showing higher levels of total Cdt1 in
asynchronous mouse ESCs than in differentiated cells (Ballabeni et al., 2011). The regulated
decrease in MCM loading rate is critical during differentiation, as rapid MCM loading protects pluri-
potency, and prematurely slowing MCM loading promotes differentiation.
Pluripotent stem cells load MCM complexes rapidly to reach similar total amounts of loaded
MCM at the G1/S transition in less time than their isogenic differentiated counterparts. Although we
did not detect substantial MCM loading in telophase, as suggested previously (Dimitrova et al.,
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Figure 7. Slow MCM loading promotes differentiation. (a) Immunofluorescence microscopy of hESCs treated with 100 nM of siControl or 100 nM of
siCdt1 for 20 hr and then treated with BMP4 as indicated. Cells were fixed and stained with DAPI (blue), Cdx2 antibody (green), and Oct4 antibody
(red). Images are one region of 18 fields-of-view per condition; scale bar is 100 mm (see Materials and methods). (b) Density scatterplots of mean
fluorescence intensity (arbitrary units) of Oct4 and Cdx2 staining for each cell in each condition, >18,000 cells were quantified per condition. See also
Figure 7—source data 1. (c) Diagram of the relationship between Oct4 and Cdx2 in pluripotent and differentiated cells as plotted in (b); color bar for
scatterplots in (b). (d) Histogram of mean fluorescence intensity ratio Cdx2/Oct4 for all cells in siControl and siCdt1 treated with 10 ng/mL BMP4 for 48
hr. Rightmost histogram bin contains all values greater than 3.5. The inset is a box-and-whiskers plot of the same data, center line is median, outer box
edges are 25th and 75th percentile, whiskers edges are 1st and 99th percentile, individual data points are lowest and highest 1%, respectively. Medians
are 0.3722, 0.9319, and means are 0.4285, 1.194 for siControl and siCdt1, respectively. Samples compared by two tailed Mann-Whitney test,
****p<0.0001. See also Figure 7—source data 1. (e) Immunoblot for Cdt1 in whole cell lysates at 20 hr of siRNA treatment, prior to BMP4 treatment. (f)
Illustration of the relationship between differentiation and MCM loading rate changes.
DOI: https://doi.org/10.7554/eLife.30473.017
The following source data and figure supplements are available for figure 7:
Source data 1. Raw image values.
DOI: https://doi.org/10.7554/eLife.30473.021
Figure supplement 1. Complete microscopy dataset and endoderm differentiation.
DOI: https://doi.org/10.7554/eLife.30473.018
Figure supplement 2. Slow MCM loading promotes differentiation.
DOI: https://doi.org/10.7554/eLife.30473.019
Figure supplement 3. Reducing MCM loading rate by an alternative siRNA targeting Cdc6 instead of Cdt1.
Figure 7 continued on next page
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2002), it is clear that telophase loading is an option in some cells and a requirement in cells with no
detectable G1 such as S. pombe and in the first nuclear divisions in D. melanogaster
(Nishitani et al., 2000; Farrell and O’Farrell, 2014). Stem cells achieve faster MCM loading, at least
in part, by particularly high Cdt1 levels in G1. These high levels are achieved not only by a modest
difference in CDT1 mRNA (Figure 3c) but also post-transcriptionally by specific re-accumulation of
Cdt1 protein in the preceding G2 phase (Figure 5c). Cdt1 stability in G2 phase has been attributed
to geminin-mediated protection from the SCFSkp2 E3 ubiquitin ligase in non-stem cells
(Tsunematsu et al., 2013; Ballabeni et al., 2004; Clijsters et al., 2013). It is not clear, however,
that geminin levels are particularly high in stem cells relative to differentiated cells (aside from differ-
ences expected from cell cycle distribution changes (Figure 5a) (Ballabeni et al., 2011)), so it seems
unlikely that geminin drives higher Cdt1 levels in stem cells. Skp2 levels also do not change in the
earliest stages of stem cell differentiation (Egozi et al., 2007). Cdt1 is protected in late S phase and
G2 by cyclin A/Cdk1 activity (Rizzardi et al., 2015), and we thus consider it likely that the docu-
mented high CDK activity in stem cells contributes to Cdt1 stabilization in G2 (Sela et al., 2012).
The anticipatory Cdt1 accumulation to promote MCM loading in G1 was originally proposed from
experiments in cancer-derived cell lines (Ballabeni et al., 2004; Clijsters et al., 2013). Our observa-
tions in stem cells suggest this strategy is employed by non-transformed cells during developmental
stages that require short G1.
Other factors besides Cdt1 accumulation may also accelerate MCM loading. The hESCs we
assayed have 2–3 fold greater Cdt1 protein levels in G1 relative to NPCs yet load MCM 6.5 times
faster per hour than NPCs. One Cdt1 molecule can (in vitro) load multiple MCM complexes since
Cdt1 is released into the soluble phase immediately after completing a loading reaction
(Ticau et al., 2015). Stem cells may experience less Cdc6 degradation in early G1 due to nearly con-
stitutive Cyclin E/Cdk2 activity and/or attenuated APCCdh1 activity, corroborated by our observation
that a Cdc6 mutant that is not targeted by APCCdh1 increases MCM loading rate in cells with long
G1 phases (Figure 6g) (Ballabeni et al., 2011; Neganova et al., 2009; Filipczyk et al., 2007). Addi-
tionally, stem cells are enriched for euchromatin, an environment that may be particularly permissive
for rapid MCM loading (Chen and Dent, 2014).
Rapid MCM loading may itself contribute to mechanisms that maintain short G1 phases in plurip-
otent cells. The origin licensing checkpoint links the amount of loaded MCM to G1 length by control-
ling Cdk2 activity. In that regard, overproducing Cyclin E ‘short-circuited’ the licensing checkpoint in
slow loading differentiated cells. This checkpoint has thus far only been demonstrated in p53-profi-
cient differentiated mammalian cells (Ge and Blow, 2009), but the G1 lengthening of hESCs after
Cdt1 depletion suggests that pluripotent stem cells also have a functioning licensing checkpoint.
Cells with fast MCM loading could satisfy this checkpoint quickly, activate Cyclin E/Cdk2, and thus
spend less time in G1. Mechanisms that support short G1 length preserve pluripotency in hESCs
(and promote reprogramming to iPSCs) since cells are most sensitive to differentiation cues in G1; in
that regard, extending G1 phase in hESCs can increase differentiation propensity (Soufi and Dalton,
2016; Pauklin and Vallier, 2013; Filipczyk et al., 2007; Coronado et al., 2013). Recent work with
quintuple knockout mice lacking all D and E type cyclins also reported that Cyclin E/Cdk2 further
contributes to maintaining pluripotency by stabilizing the Oct4, Sox2, and Nanog transcription fac-
tors (Liu et al., 2017). Fast MCM loading may have evolved as an intrinsic property of pluripotent
cells to maintain high Cdk2 activity and keep G1 phase short.
Cyclin/Cdk activity is not the sole connection between the cell cycle and pluripotency. Non-CDK
cell-cycle-associated proteins regulate expression of key pluripotency genes including SOX2 and
NANOG (Gonzales et al., 2015; Pauklin et al., 2016; Li et al., 2012). Pluripotency transcription fac-
tors themselves regulate expression of cell cycle genes including those encoding cyclins, CDK inhibi-
tors, and E2F3a (Lee et al., 2010; Kanai et al., 2015; Choi et al., 2012). On the other hand,
pluripotency and cell cycle functions can be genetically uncoupled in experiments where manipulat-
ing the cell cycle did not alter pluripotency and vice versa (Scognamiglio et al., 2016; Kareta et al.,
2015b). We observe that licensing inhibition can accelerate differentiation even without greatly
Figure 7 continued
DOI: https://doi.org/10.7554/eLife.30473.020
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lengthening G1 (Figure 7—figure supplements 2,3) which may point to an additional direct and
cell cycle-independent link between MCM loading rate and differentiation.
We note that early differentiation is not the only setting in which rapid MCM loading during a
short G1 may be relevant. Like hESCs, activated T cells have very fast cell cycles with short G1
phases (Kinjyo et al., 2015). Oncogenic transformation is also frequently associated with G1 short-
ening. It may be that the pathways linking differentiation to MCM loading rate are also coopted in
some cancers to induce rapid licensing. On the other hand, a subset of cancers may proliferate in a
perpetually underlicensed state that contributes to the genome instability characteristic of trans-
formed cells. Future investigations will elucidate the molecular relationships among developmental
signaling pathways, MCM loading rate, and cell cycle remodeling.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background
(Escherichia coli)
E. coli: DH5a Invitrogen Cat#11319019
Genetic
reagent
(Homo sapiens)
Rc/CMV cyclin E Hinds et al. (1992)
PMID: 1388095
Addgene 8963
Genetic
reagent
(Homo sapiens)
pInducer20 Meerbrey et al., 2011
PMID: 21307310
Addgene 44012
Genetic
reagent
(Homo sapiens)
DNRF Dr. J. Bear N/A
Genetic
reagent
(Homo sapiens)
VSVG Dr. J. Bear N/A
Genetic
reagent
(Homo sapiens)
pInducer20-Cyclin E1 This Paper N/A see Materials
and methods
Genetic
reagent
(Homo sapiens)
pDONR221 Invitrogen Cat#12536017
Genetic
reagent
(Homo sapiens)
pENTR221-Cyclin E1 This Paper N/A
Genetic
reagent
(Homo sapiens)
PCR4-TOPO Invitrogen Cat# 450030
Genetic
reagent
(Homo sapiens)
pInducer20-blast This Paper N/A see Materials
and methods
Genetic
reagent
(Homo sapiens)
pInducer20-blast-Cdt1-HA This Paper N/A see Materials
and methods
Genetic
reagent
(Homo sapiens)
CLXSN-5myc-Cdc6-wt This Paper N/A see Materials
and methods
Genetic
reagent
(Homo sapiens)
CLXSN-5myc-Cdc6-mut This Paper N/A see Materials
and methods
Cell
line (Homo sapiens)
male
T98G ATCC Cat#CRL-1690
Continued on next page
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Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Cell line
(Homo sapiens)
female
RPE1-hTERT ATCC Cat#CRL-4000
Cell line
(Homo sapiens)
male
ARPE-19 ATCC Cat#CRL-2302
Cell line
(Homo sapiens)
female
H9 hESC (WA09) WiCell hPSCReg ID:
WAe009-A
Cell line
(Homo sapiens)
male
NPC This Paper N/A see Materials
and methods
Cell line
(Homo sapiens)
female
HEK293T ATCC Cat# CRL-3216
Cell line
(Homo sapiens)
male
ARPE-iPSC This Paper N/A see Materials
and methods
Antibody Anti-Mcm2,
mouse monoclonal
(BM28)
BD Biosciences Cat#610700;RRID:
AB_2141952
1:10,000 (IB)
1:200 (FC)
Antibody Anti-Mcm3,
rabbit
polyclonal
Bethyl
Laboratories
Cat#A300-192A;
RRID: AB_162726
1:10,000 (IB)
1:200
(FC)
Antibody Anti-Cdt1,
rabbit monoclonal
(D10F11) (immunoblots)
Cell
Signaling
Technologies
Cat#8064S;
RRID: AB_10896851
1:10,000 (IB)
Antibody Anti-Cdt1,
rabbit monoclonal
(EPR17891)
(flow cytometry)
Abcam Cat#ab202067;
RRID:AB_2651122
1:100 (FC)
Antibody Anti-Cdc6,
mouse monoclonal
(180.2)
Santa
Cruz
Biotechnology
Cat#sc-9964;
RRID: AB_627236
1:2000 (IB)
Antibody Anti-Oct4,
rabbit polyclonal
(immunoblots)
Abcam Cat#ab19857;
RRID: AB_445175
1:4000 (IB)
Antibody Anti-Oct4,
mouse monoclonal (9B7)
(microscopy)
Millipore Cat#:MABD76;
RRID: AB_10919170
1:1000 (IF)
Antibody Anti-Cdx2,
rabbit monoclonal
(EPR2764Y)
Abcam Cat#ab76541;
RRID: AB_1523334
1:1000 (IF)
Antibody Anti-Sox17,
goat polyclonal
R and D Systems Cat#AF1924;
RRID: AB_355060
1:500 (IF)
Antibody Anti-Cyclin E1,
rabbit polyclonal
Santa
Cruz
Biotechnology
Cat#sc-198;
RRID: AB_631346
1:2000 (IB)
Antibody Anti-Orc1,
rabbit polyclonal
Bethyl
Laboratories
Cat#A301-892A;
AB_1524103
1:1000 (IB)
Antibody Anti-Orc6,
rat monoclonal (3A4)
Santa
Cruz
Biotechnology
Cat#sc-32735;
RRID: AB_670295
1:5000 (IB)
Antibody Anti-geminin,
rabbit polyclonal
Santa
Cruz
Biotechnology
Cat#sc-13015;
RRID: AB_2263394
1:3000 (IB)
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Antibody Anti-Histone H3, rabbit
monoclonal (D1H2)
Cell
Signaling
Technologies
Cat#4499S;
RRID: AB_10544537
1:10,000 (IB)
Antibody Anti-TRA-1–60,
mouse
monoclonal (cl.A)
Invitrogen Cat#41–1000;
RRID: AB_605376
1:5000 (IB)
Antibody Anti-nestin,
mouse monoclonal
(10 C2)
Abcam Cat#ab22035;
RRID: AB_446723
1:10000 (IB)
Antibody Anti-TRA-1–60
mouse (
immunofluorescence)
Millipore/Chemicon Cat# MAB4360;
RRID: AB_2119183
1:400 (IF)
Antibody Anti-TRA-81
mouse
(immunofluorescence)
Millipore/Chemicon Cat# MAB4381;
RRID:AB_177638
1:400 (IF)
Antibody Anti-SSEA-4
mouse (MC-813–70)
(immunofluorescence)
Millipore/Chemicon Cat# MAB4304;
RRID:AB_177629
1:200 (IF)
antibody Anti-SSEA3
rabbit (MC-631)
(immunofluorescence)
Millipore/Chemicon Cat# MAB4303;
RRID:AB_177628
1:200 (IF)
Antibody Anti-Oct3/4
goat polyclonal
(immunofluorescence)
Abcam Cat# ab27985;
RRID:AB_776898
1:200 (IF)
Antibody Anti-NANOG
goat polyclonal
(immunofluorescence)
Everest Biotech Cat# EB068601;
RRID:AB_2150379
1:200 (IF)
Antibody Anti-p27
rabbit polyclonal
Santa
Cruz
Biotechnology
Cat#sc-528;
RRID:AB_632129
1:2000 (IB)
Antibody Anti-a-tubulin Sigma Aldrich Cat#9026 1:50000 (IB)
Antibody Goat anti-Mouse-HRP Jackson ImmunoResearch Cat#115-035-146;
RRID: AB_2307392
1:10000 (IB)
Antibody Donkey anti-Rabbit-HRP Jackson ImmunoResearch Cat#711-035-152;
RRID: AB_10015282
1:10000 (IB)
Antibody Bovine anti-Goat-HRP Jackson ImmunoResearch Cat#805-035-180;
RRID: AB_2340874
1:10000 (IB)
Antibody Donkey anti-Rat-HRP Jackson ImmunoResearch Cat#712-035-153;
RRID: AB_2340639
1:10000 (IB)
Antibody Donkey anti-Goat-Alexa 594 Jackson ImmunoResearch Cat#705-585-147;
RRID: AB_2340433
1:1000 (IF)
Antibody Donkey anti-Rabbit-Alexa 488 Life Technologies Cat#A21206;
RRID: AB_2535792
1:1000 (IF) (FC)
Antibody Goat anti-Mouse-Alexa 594 Life Technologies Cat#A11032;
RRID: AB_2535792
1:1000 (IF)
Antibody Donkey
anti-Rabbit
-Alexa 647
Jackson ImmunoResearch Cat#711-605-152;
RRID: AB_2492288
1:1000 (FC)
Antibody Donkey anti
-Mouse-
Alexa 488
Jackson ImmunoResearch Cat#715-545-150;
RRID: AB_2340845
1:1000 (FC)
Sequence-based
reagent
siCdt1- CCUACGUCAA
GCUGGACAATT
Nevis et al. (2009)
PMCID: PMC2972510
N/A
Sequence-based
reagent
siCdc6-2534-
CACCAUGCUCAGCC
AUUAAGGUAUU
Nevis et al. (2009)
PMCID: PMC2972510
N/A
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Sequence-based
reagent
siCdc6-2144-
UCUAGCCAAUGUGC
UUGCAAGUGUA
Nevis et al. (2009)
PMCID: PMC2972510
N/A
Sequence-based
reagent
siControl (Luciferase)-
CUUACGCUGA
GUACUUCGA
Coleman et al. (2015)
PMID: 26272819
N/A
Sequence-based
reagent
siMCM3-2859 5’- augacuauu
gcaucuucauug
This paper synthesized
by
invitrogen
Sequence-based
reagent
siMCM3-2936 5’- aacauauga
cuucugaguacu
This paper synthesized
by
invitrogen
Sequence-based
reagent
POU5F1-F: 5’-CCTGAAGCAGA
AGAGGATCACC,
Eton Bioscience
Sequence-based
reagent
POU5F1-R 5’-AAAGCGGCAGA
TGGTCGTTTGG,
Eton Bioscience
Sequence-based
reagent
CDX2-F 5’-ACAGTCGCTA
CATCACCATCCG,
Eton Bioscience
Sequence-based
reagent
CDX2-R 5’-CCTCTCCT
TTGCTCTGCGGTTC,
Eton Bioscience
Sequence-based
reagent
T-F 5’-CTTCAGCA
AAGTCAAGCTCACC,
Eton Bioscience
Sequence-based
reagent
T-R 5’-TGAACTGGGTCT
CAGGGAAGCA,
Eton Bioscience
Sequence-based
reagent
SOX17-F 5’-ACGCTTTCA
TGGTGTGGGCTAAG,
Eton Bioscience
Sequence-based
reagent
SOX17-R 5’-GTCAGCGC
CTTCCACGACTTG,
Eton Bioscience
Sequence-based
reagent
CDT1-F 5’-GGAGGTCAGAT
TACCAGCTCAC,
Eton Bioscience
Sequence-based
reagent
CDT1-R, 5’-TTGACGTGC
TCCACCAGCTTCT,
Eton Bioscience
Sequence-based
reagent
SOX2-F 5’-CTACAGCAT
GATGCAGGACCA,
Eton Bioscience
Sequence-based
reagent
SOX2-R 5’-TCTGCGAGCT
GGTCATGGAGT,
Eton Bioscience
Sequence-based
reagent
PAX6-F 5’-AATCAGAG
AAGACAGGCCA,
Eton Bioscience
Sequence-based
reagent
PAX6-R 5’-GTGTAGGTA
TCATAACTC,
Eton Bioscience
Sequence-based reagent ACTB-F 5’-CACCATTGGC
AATGAGCGGTTC,
Eton Bioscience
Sequence-based
reagent
ACTB-R 5’-AGGTCTTTGC
GGATGTCCACGT
Eton Bioscience
Sequence-based
reagent
CDC6-KEN-F: 5- ctccaccaaagc
aaggcaaggcggc
cgcaggtccccc
tcactcacatacac
Eurofins
Sequence-based
reagent
CDC6-KEN-R: 5- GTGTATGTGAGTGAGG
GGGACCTGCG
GCCGCCTTGCCTTGCTTTGGTGGAG
Eurofins
Sequence-based
reagent
CDC6-DBOX-F: 5- aagccctgcctct
cagccccgccaaacgt
gccggcgatgacaa
cctatgcaa
Eurofins
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Sequence-based
reagent
CDC6-DBOX-R: 5- TTGCATAGGTTGTCA
TCGCCGGCACGTTT
GGCGGGGCTGA
GAGGCAGGGCTT
Eurofins
Sequence-based
reagent
AgeI-rta3-F: 5- gctcggatctccacc
ccgtaccggtcctg
cagtcgaattcac
Eurofins
Sequence-based
reagent
AgeI-IRES-blast-R: 5-
ACAAAGGCTTGGC
CATGGTTTAAGCTTATCA
TCGTGTTTTTCA
Eurofins
Sequence-based
reagent
Blast-F:5- tgaAaaacacgat
gataagctt
aaaccatggc
caagcctttgt
Eurofins
Sequence-based
reagent
Blast-AgeI-Ind-R: 5-
GTTCAATCATGG
TGGACCGG
CTATTAGCCCTCCCAC
ACATAACCA
Eurofins
Sequence-based
reagent
BP-cycE-F 5’
GGGGACAAGTTTGTAC
AAAAAAGCAGGC
TACCATGAAGGAG
GACGGCGGC
Eurofins
Sequence-based
reagent
BP-cycE-R 5’
GGGGACCACTTTG
TACAAGAAAGCTGG
GTTCACGCCATT
TCCGGCCCGCT
Eurofins
Software, algorithm MATLAB MathWorks https://www.math
works.com/
Software, algorithm GraphPad Prism 7 GraphPad Software https://www.graphpad
.com/scientific-
software/prism/
Software, algorithm NIS-Elements
Advanced Research
Software
Nikon https://www.nikonin
struments
.com/Products
/Software/
NIS-Elements-
Advanced-Research
Software, algorithm CellProfiler Carpenter et al., 2006
PMC1794559
http://cellprofiler.org/
Software, algorithm FCS Express 6 De Novo Software https://www.denovo
software.com/
Software, algorithm FCSExtract Utility Earl F Glynn http://research.
stowers.org/mcm
/efg/Scientific
Software/
Utility/FCSExtract/
index.htm
Software, algorithm QUMA RIKEN http://quma.
cdb.
riken.jp
Software, algorithm Adobe Photoshop CS6 Adobe http://www.adobe.
com/
products/
photoshop.html
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Commercial assay
or kit
CytoTune-iPS 2.0 Sendai
reprogramming kit
Invitrogen Cat#A16517
Commercial assay
or kit
DNeasy Blood and
Tissue kit
Qiagen Cat#69504
Commercial assay
or kit
RNeasy Mini kit Qiagen Cat#74104
Commercial assay
or kit
Epitect Bisulfite kit Qiagen Cat#59104
Commercial assay
or kit
Norgen Biotek’s Total
RNA Purification Kit
Norgen Biotek Cat#37500
Commercial assay or
kit
Applied Biosystem’s
High-Capacity RNA-to-cDNA
Applied Biosystem Cat#4387406
Commercial assay or
kit
Alkaline Phosphatase
Detection Kit
Millipore Cat# SCR004
Commercial assay or
kit
QIAquick Gel
Extraction kit
Qiagen Cat# 28704
Chemical compound,
drug
DAPI Life Technologies Cat#D1306
Chemical compound,
drug
EdU Santa Cruz Biotechnology Cat#sc-284628
Chemical compound,
drug
Ponceau S Sigma Aldrich Cat#P7170-1L
Peptide, recombinant
protein
BMP4 Protein R and D Systems Cat#314 BP-010
Peptide,
recombinant
protein
Activin A Protein R and D Systems Cat#338-AC-010
Chemical compound,
drug
Y-27632 2HCl Selleck Chemicals Cat#S1049
Chemical compound,
drug
CHIR-99021 Selleck Chemicals Cat#S2924
Chemical compound,
drug
mTESR1 Stem Cell Technologies Cat#05850
Chemical compound,
drug
STEMdiff Neural
Induction Medium
Stem Cell Technologies Cat#05835
Chemical compound,
drug
STEMdiff Neural
Progenitor Medium
Stem Cell Technologies Cat#05833
Chemical compound,
drug
Essential 8 Medium Life Technologies Cat#A1517001
Chemical compound,
drug
Doxycycline CalBiochem Cat#324385
Chemical compound,
drug
Alexa 647-azide Life Technologies Cat#A10277
Chemical compound,
drug
Alexa 488-azide Life Technologies Cat#A10266
Chemical compound,
drug
Hydroxyurea Alfa Aesar Cat#A10831
Chemical
compound, drug
Corning
Matrigel GFR
Membrane Matrix
Corning Cat#CB-40230
Chemical compound,
drug
Poly-L-Ornithine Sigma Aldrich Cat#P4957-50ML
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Chemical compound,
drug
Laminin Sigma Aldrich Cat#L2020-1MG
Chemical compound,
drug
ReLesR Stem Cell Technologies Cat#05872
Cell culture
Cell lines were authenticated by STR profiling (ATCC, Manassas, VA) and confirmed to be myco-
plasma negative. T98G, HEK293T, and RPE1-hTERT were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 2 mM L-glutamine and 10% fetal bovine serum (FBS) and incu-
bated in 5% CO2 at 37˚C. ARPE-19 (male) were cultured in 1:1 DMEM:F12 supplemented with 2 mM
L-glutamine and 10% fetal bovine serum and incubated in 5% CO2 at 37˚C. T98G, HEK293T, RPE1-
hTERT, and ARPE-19 cells were from the ATCC and were passaged with trypsin and not allowed to
reach confluency. WA09 (H9 hESCs) were cultured in mTeSR1 (StemCell Technologies) with media
changes every 24 hr on Matrigel (Corning, New York, NY) coated dishes and incubated in 5% CO2
at 37˚C. H9s had normal diploid karyotype at passage 32 and were used from passage 32–42. ARPE-
iPSCs were cultured in Essential 8 (Life Technologies, Grand Island, NY) with media changes every
24 hr on Matrigel (Corning) coated dishes and incubated in 5% CO2 at 37˚C. iPSCs were used from
passage 20–25 and had normal karyotype. Both hESCs and iPSCs were routinely passaged every 4
days as aggregates using ReLeSR, according to manufacturer’s instructions (StemCell
Technologies, Canada). The hESCs and iPSCs were only passaged as single cells in 10 mM Y-27632
2HCl (Selleck Chemicals, Houston, TX) for experiments, as described previously (Watanabe et al.,
2007). NPCs were cultured in Neural Progenitor Medium (StemCell Technologies) with media
changes every 24 hr on poly-L-ornithine/Laminin (Sigma Aldrich, St. Louis, MO) coated dishes and
incubated in 5% CO2 at 37˚C. NPCs were passaged with StemPro Accutase (Gibco, Waltham, MA)
weekly.
Total lysate and chromatin fractionation
Cells were collected via trypsinization. For total protein lysates, cells were lysed on ice for 20 min in
CSK buffer (300 mM sucrose, 100 mM NaCl, 3 mM MgCl2, 10 mM PIPES pH 7.0) with 0.5% triton
x-100 and protease and phosphatase inhibitors (0.1 mM AEBSF, 1 mg/ mL pepstatin A, 1 mg/ mL leu-
peptin, 1 mg/ mL aprotinin, 10 mg/ ml phosvitin, 1 mM b-glycerol phosphate, 1 mM Na- orthovana-
date). Cells were centrifuged at 13,000 xg at 4˚C for 5 min, then the supernatants were transferred
to a new tube for a Bradford Assay (Biorad, Hercules, CA) using a BSA standard curve. Chromatin
fractionation for immunoblotting was performed as described previously (Cook et al., 2002;
Me´ndez and Stillman, 2000), using CSK buffer with 1 mM ATP, 5 mM CaCl2, 0.5% triton x-100 and
protease and phosphatase inhibitors to isolate insoluble proteins and S7 nuclease (Roche) to release
DNA bound proteins. A Bradford Assay (Biorad) was performed for equal loading. For 100 mM or
300 mM NaCl soluble/pellet fractionation, cells were lysed in standard CSK (100 mM NaCl) or high-
salt CSK (300 mM NaCl) with 0.5% triton X-100 with protease and phosphatase inhibitors for 5 min
on ice. Then cells were centrifuged at 2000 xg for 3 min, supernatants transferred to a new tube as
the soluble fraction. The remaining pellet was suspended in 2x SDS loading buffer (2% SDS, 5% 2-
mercaptoethanol, 0.1% bromophenol blue, 50 mM Tris pH 6.8, 10% glycerol) as the pellet fraction.
Bradford assay was performed on the soluble fraction for equal loading.
Immunoblotting
Samples were diluted with SDS loading buffer (final: 1% SDS, 2.5% 2-mercaptoethanol, 0.1% bromo-
phenol blue, 50 mM Tris pH 6.8, 10% glycerol) and boiled. Samples were run on SDS-PAGE gels,
then the proteins transferred onto polyvinylidene difluoride membranes (Thermo
Fisher, Waltham, MA) or nitrocellulose (GE Healthcare, Chicago, IL). Membranes were blocked at
room temperature for 1 hr in either 5% milk or 5% BSA in Tris-Buffered-Saline-0.1%-tween-20
(TBST). After blocking, membranes were incubated in primary antibody overnight at 4˚C in either
1.25% milk or 5% BSA in TBST with 0.01% sodium azide. Blots were washed with TBST then
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incubated in HRP-conjugated secondary antibody in either 2.5% milk or 5% BSA in TBST for 1 hr,
washed with TBST, and then membranes were incubated with ECL Prime
(Amersham, United Kingdom) and exposed to autoradiography film (Denville, Holliston, MA). Equal
protein loading was verified by Ponceau S staining (Sigma Aldrich). Antibodies used for immunoblot-
ting were: Mcm2, (BD Biosciences, San Jose, CA, Cat#610700), Mcm3, (Bethyl
Laboratories, Montgomery, TX, Cat#A300-192A), Cdt1, (Cell Signaling Technologies, Beverly, MA,
Cat#8064S), Cdc6, (Santa Cruz Biotechnology, Santa Cruz, CA, Cat#sc-9964), Oct4, (Abcam, Cam-
bridge, MA, Cat#ab19857),Cyclin E1, (Santa Cruz Biotechnology, Cat#sc-198), Orc1, (Bethyl Labora-
tories, Cat#A301-892A), Orc6, (Santa Cruz Biotechnology, Cat#sc-32735), geminin, (Santa Cruz
Biotechnology, Cat#sc-13015), Histone H3, (Cell Signaling Technologies, Cat#4499S), TRA-1–60,
(Invitrogen, Cat#41–1000), nestin, (Abcam, Cat#ab22035), p27 (Santa Cruz Biotechnology, Cat#sc-
528), a-tubulin (Sigma Aldrich, Cat#9026).
Flow cytometry
For EdU-labeled samples, cells were incubated with 10 uM EdU (Santa Cruz Biotechnology) for 30
min prior to collection. For total protein flow cytometry, cells were collected with trypsin and resus-
pended as single cells, washed with PBS, and fixed with 4% paraformaldehyde (Electron Microscopy
Sciences, Hatfield, PA) in PBS for 15 min at room temperature, then 1% BSA-PBS was added, mixed
and cells were centrifuged at 1000 xg for 7 min (and for all following centrifuge steps) then washed
with 1% BSA-PBS and centrifuged. Fixed cells were permeabalized with 0.5% triton x-100 in 1%
BSA-PBS at room temperature for 15 min, centrifuged, then washed once with 1% BSA, PBS and
centrifuged again before labeling. For chromatin flow cytometry, cells were collected with trypsin
and resuspended as single cells, washed with PBS, and then lysed on ice for 5 min in CSK buffer with
0.5% triton x-100 with protease and phosphatase inhibitors. Next, 1% BSA-PBS was added and
mixed, then cells were centrifuged for 3 min at 1000 xg, then fixed in 4% paraformaldehyde in PBS
for 15 min at room temperature. For 100 mM NaCl vs 300 mM NaCl CSK, cells were processed as in
chromatin flow cytometry above, except CSK containing 300 mM NaCl was used instead of the nor-
mal 100 mM NaCl. Next, 1% BSA-PBS was added, mixed and cells were centrifuged then washed
again before labeling. The labeling methods for total protein samples and chromatin samples were
identical. For DNA synthesis (EdU), samples were centrifuged and incubated in PBS with 1 mM
CuSO4, 1 mM fluorophore-azide, and 100 mM ascorbic acid (fresh) for 30 min at room temperature
in the dark. 1% BSA-PBS +0.1% NP-40 was added, mixed and centrifuged. Samples were resus-
pended in primary antibody in 1% BSA-PBS +0.1% NP-40 and incubated at 37˚C for 1 hr in the dark.
Next, 1% BSA-PBS +0.1% NP-40 was added, mixed and centrifuged. Samples were resuspended in
secondary antibody in 1% BSA-PBS +0.1% NP-40 and incubated at 37˚C for 1 hr in the dark. Next,
1% BSA-PBS +0.1% NP-40 was added, mixed and centrifuged. Finally, cells were resuspended in 1%
BSA-PBS +0.1% NP-40 with 1 mg/mL DAPI (Life Technologies) and 100 mg/mL RNAse A (Sigma
Aldrich) and incubated overnight at 4˚C in the dark. Samples were run on a CyAn ADP flow cytome-
ter (Beckman Coulter, Brea, CA) and analyzed with FCS Express six software (De
Novo, Glendale, CA). The following antibody/fluorophore combinations were used: (1): Alexa 647-
azide (Life Technologies), primary: Mcm2 (BD Biosciences, Cat#610700), secondary: Donkey anti-
mouse-Alexa 488 (Jackson ImmunoResearch), DAPI. (2): Alexa 488-azide (Life Technologies), pri-
mary: Cdt1 (Abcam, Cat#610700), secondary: Donkey anti-rabbit-Alexa 647 (Jackson ImmunoRe-
search), DAPI. (3): Alexa 647-azide (Life Technologies), primary: Mcm3 (Bethyl Cat#A300-192A),
secondary: Donkey anti-rabbit-Alexa 488 (Jackson ImmunoResearch), DAPI. (4): primary: Mcm3
(Bethyl Cat#A300-192A), Mcm2 (BD Biosciences, Cat#610700), secondary: Donkey anti-mouse-Alexa
488, Donkey anti-rabbit-Alexa 647 (Jackson ImmunoResearch, West Grove, PA), DAPI. Cells were
gated on FS-area vs SS-area. Singlets were gated on DAPI area vs DAPI height. The positive/nega-
tive gates for EdU and MCM were gated on a negative control sample, which was treated with nei-
ther EdU nor primary antibody, but incubated with 647-azide and the secondary antibody Donkey
anti-mouse-Alex 488 and DAPI to account for background staining (Figure 1—figure supplement
1).
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Doubling time
Doubling time was calculated by plating equal number of cells as described above and counting cell
number over time using a Luna II automated cell counter (Logos Biosystems, South Korea) at 24, 48,
and 72 hr after plating. Three or four wells were counted as technical replicates at each timepoint.
GraphPad Prism’s regression analysis was used to compute doubling time, and multiple biological
replicates were averaged for a final mean doubling time. ARPE-19s were counted four times, hESCs
and NPCs three times, and iPSCs two times.
Cell synchronization and treatments
To synchronize cells in G1, T98G cells were grown to 100% confluency, washed with PBS, and incu-
bated for 72 hr in 0.1% FBS, DMEM, L-glutamine. After serum-starvation, cells were re-stimulated by
passaging 1:3 with trypsin to new dishes in 20% FBS, DMEM, L-glutamine, collecting cells 10 hr and
12 hr post-stimulation. To synchronize T98G cells in early S phase, cells were treated as for G1,
except 1 mM Hydroxyurea (Alfa Aesar, Haverhill, MA) was added to the media upon re-stimulating
and cells were collected 18 hr post-stimulation. To synchronize cells in mid-late S, cells were treated
as in early S, then at 18 hr post-stimulation cells were washed with PBS and released into 10% FBS,
DMEM, L-Glutamine, collecting 6 hr, 8 hr post release.
To synchronize RPE1-hTERT cells in G0, cells were grown to 100% confluency, then incubated for
48 hr in 10% FBS, DMEM, L-glutamine. For RPE1 in G1/S, G0 cells were trypsinized and passaged
1:6 with trypsin to new dishes in 10% FBS, DMEM, L-glutamine, and collected with trypsin 22 hr
later. For cycloheximide (Sigma) treatment, asynchronous RPE cells were treated with 10 ug/mL for 4
hr or 8 hr as indicated. For UV irradiation, asynchronous RPE cells were treated with 20 J/m2 of UV
with a Stratalinker (Stratagene, San Diego, CA) and collected 1 hr later.
Cloning
The pInducer20-Cyclin E plasmid was constructed using the Gateway cloning method (Invitrogen).
The attB sites were added to Cyclin E1 cDNA by PCR using Rc/CMV cyclin E plasmid as a template
and BP-cycE-F (5’ GGGGACAAGTTTGTACAAAAAAGCAGGCTACCATGAAGGAGGACGGCGGC)
and BP-cycE-R primers (5’ GGGGACCACTTTGTACAAGAAAGCTGGGTTCACGCCA
TTTCCGGCCCGCT) (Hinds et al., 1992). The PCR product was recombined with pDONR221 plas-
mid using BP clonase (Invitrogen) according to the manufacturer’s instructions and transformed into
DH5a to create pENTR221-Cyclin E1. Then the LR reaction was performed between pInducer20 and
pENTR221-Cyclin E1 using LR Clonase (Invitrogen, Carlsbad, CA) according to manufacturer’s
instructions and transformed into DH5a to create pInducer20-Cyclin E1. The pInducer20 plasmid
was converted to blasticidin resistance (pInducer20-blast2) by Gibson Assembly (New England
Biolabs, Ipswitch, MA) following manufacturer’s protocol. pInducer20 was cut with AgeI and assem-
bled with PCR products with the following primers:
AgeI-rta3-F: 5- gctcggatctccaccccgtaccggtcctgcagtcgaattcac
AgeI-IRES-blast-R: 5- ACAAAGGCTTGGCCATGGTT TAAGCTTATCATCGTGTTTTTCA
Blast-F:5- tgaAaaacacgatgataagcttaaaccatggccaagcctttgt
Blast-AgeI-Ind-R: 5- GTTCAATCATGGTGGACCGG CTATTAGCCCTCCCACACATAACCA
The pLenti CMV blast plasmid was a template for the blasticidin resistance gene. A tagged Cdt1-
HA was cloned into pInducer20-blast using Gateway cloning as described above.
The Cdc6 mutant unable to bind APCCDH1 (5myc-Cdc6-mut) was described previously: R56A,
L59A, K81A, E82A, N83A (Petersen et al., 2000). pCLXSN-5myc-Cdc6-wt was cloned to 5myc-
Cdc6-mut by two sequential Gibson assemblies (NEB) according to manufacturer’s instructions. Pri-
mers used:
CDC6-KEN-F: 5- ctccaccaaagcaaggcaaggcggccgcaggtccccctcactcacatacac
CDC6-KEN-R: 5- GTGTATGTGAGTGAGGGGGACCTGCGGCCGCCTTGCCTTGCTTTGGTGGAG
CDC6-DBOX-F: 5- aagccctgcctctcagccccgccaaacgtgccggcgatgacaacctatgcaa
CDC6-DBOX-R: 5- TTGCATAGGTTGTCATCGCCGGCACGTTTGGCGGGGCTGAGAGG-
CAGGGCTT
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Cell line construction and inducible protein production
To package retrovirus, pCLXSN 5myc-Cdc6 wt or mut were co-transfected with pCI-GPZ and VSVG
plasmids into HEK293T using 50 mg/mL Polyethylenimine-Max (Aldrich Chemistry).To package lenti-
virus, pInducer20-Cyclin E1 or pInducer20-blast2-Cdt1-HA wwere co-transfected with DNRF and
VSVG plasmids into HEK293T using 50 mg/mL Polyethylenimine-Max (Aldrich Chemistry). Viral super-
natant was transduced with 8 ug/mL Polybrene (Millipore, Burlington, MA) onto RPE1-hTERT cells
overnight. Cells were selected with 500 ug/mL neomycin (Gibco) or 5 mg/mL blasticidin (Research
Products International, Mount Prospect, IL) for 1 week. To overproduce Cyclin E1, cells were treated
with 100 ng/mL doxycycline (CalBiochem, San Diego, CA) for 72 hr in 10% FBS, DMEM, L-glutamine.
Control cells were the Inducer20-Cyclin E1 without doxycycline. To overproduce Cdt1, cells were
treated with 100 ng/mL doxycycline for 48 hr in 10% FBS, DMEM, L-glutamine, control cells were
without doxycycline.
siRNA transfections
For siRNA treatment, Dharmafect 1 (Dharmacon, Lafayette, CO) was mixed in mTeSR1 with the
appropriate siRNA according to the manufacturer’s instructions, then diluted with mTeSR1 and
added to cells after aspirating old media. The final siRNA concentrations were: 100 nM siControl
(Luciferase), 25 or 100 nM siCdt1, or a mixture of two siCdc6 (2144 and 2534 at 50 nM each). The
Cdt1 siRNA mix was incubated on cells for either 20 or 24 hr, then changed to new mTeSR1 without
siRNA. The Cdc6 siRNA mix was incubated on cells for 24 hr, then changed to new mTeSR1 without
siRNA for 8 hr (32 total hours). The Cdt1, Cdc6 and Luciferase siRNA were described previously
(Coleman et al., 2015; Nevis et al., 2009). For siRNA treatment of RPE cells, Dharmafect 1 (Dhar-
macon) was mixed in Optimem (Gibco) with the appropriate siRNA according to manufacturer’s
instructions, then diluted with DMEM, 10% FBS, L-glutamine and added to cells after aspirating old
media. The next day, the siRNA mix was aspirated and replaced with fresh DMEM, 10% FBS, L-gluta-
mine, collecting samples 72 hr after the start of siRNA treatment. The siRNA were siControl (Lucifer-
ase) at 100 nM or a mixture of two MCM3 siRNA (2859 and 2936 at 50 nM each).
siMCM3-2859 5’- augacuauugcaucuucauugdTdT
siMCM3-2936 5’- aacauaugacuucugaguacudTdT
Differentiation
Mesoderm (BMP4): hESCs were passaged as single cells at 7  103/ cm2 in mTeSR1 with 10 mM
Y-27632 2HCl onto Matrigel-coated plates. 24 hr later, the media was changed to start differentia-
tion with fresh mTeSR1 with 100 ng/mL BMP4 (R and D Systems, Minneapolis, MN), and 24 hr later
the media was changed to fresh mTeSR1 with 100 ng/mL BMP4 for 48 total hours of differentiation.
Neuroectoderm: hESCs were differentiated using a monolayer-based protocol in Neural Induction
Medium: hESCs were passaged as single cells at 5.2  104/ cm2 in STEMdiff Neural Induction
Medium (StemCell Technologies) with 10 mM Y-27632 2HCl onto Matrigel coated plates, and plating
started the differentiation. 24 hr later, the media was changed to fresh Neural Induction Medium for
another 24 hr for 48 hr total differentiation. To derive NPCs, hESCs were differentiated in Neural
Induction medium (StemCell Technologies) using the Embryoid Body Neural Induction protocol
according to manufacturer’s instructions, similar to previous reports (Robinson et al., 2016). Once
generated, NPCs were maintained in Neural Progenitor Medium (StemCell Technologies).
Mesoderm (GSK3bi): hESCs were passaged as single cells at 3  104/ cm2 in mTeSR1 with 10 mM
Y-27632 2HCl onto Matrigel-coated plates. 24 hr later, the media was changed to start differentia-
tion. Cells were washed with Advanced RPMI 1640 (Gibco), then incubated in Advanced RPMI 1640
with B27 minus insulin (Gibco), 2 mM L-glutamine, and 8 mM CHIR-99021 (Selleck Chemicals). At 24
hr after changing the media, cells were washed with Advanced RPMI 1640 then incubated in
Advanced RPMI 1640 with B27 minus insulin (Gibco), 2 mM L-glutamine, without CHIR-99021 for 24
hr for a total of 48 hr of differentiation.
Endoderm: hESCs were passaged as single cells at 4  103/ cm2 in mTeSR1 with 10 mM Y-27632
2HCl onto Matrigel-coated plates. The next day, the media was changed to fresh mTeSR1 without
Y-27632 2HCl. 24 hr later, the media was changed to start differentiation. The cells were washed
with Advanced RPMI 1640 (Gibco), then incubated in Advanced RPMI 1640 with 0.2% FBS, 2 mM
L-glutamine, 100 ng/mL Activin A (R and D Systems) and 2.5 mM CHIR-99021. At 24 hr after
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changing the media, cells were washed with Advanced RPMI 1640 then incubated in Advanced
RPMI 1640 with 0.2% FBS, 2 mM L-glutamine, 100 ng/mL Activin A, without CHIR-99021 for 24 hr
for a total of 48 hr of differentiation.
Phase contrast microscopy
Phase contrast images were acquired with an Axiovert 40 CFL inverted microscope, 20x
objective (Zeiss, Germany).
Immunofluorescence microscopy
For immunofluorescence microscopy, hESCs were plated as single cells in mTeSR1 with 10 mM
Y-27632 2HCl in Matrigel-coated, 24 well, #1.5 glass bottom plates (Cellvis) at 7  103/ cm2 for
siCdt1, Mesoderm (BMP4), at 5  103 for siCdc6, Mesoderm (BMP4), and at 4  103/ cm2 for siCdt1,
Endoderm. Cells were incubated with siCdt1 for 20 hr (Mesoderm (BMP4)), 24 hr (Endoderm) or
siCdc6 for 32 hr (Mesoderm [BMP4]) all in parallel with siControl as described above (siRNA transfec-
tions). After siRNA treatment, cells were differentiated as described above (Differentiation) with the
following modifications: For Mesoderm (BMP4), multiple BMP4 concentrations and treatment times
were used as indicated (Figure 7, Figure 7—figure supplement 1). For treatment less than 48 hr,
cells were incubated in mTeSR1 after siRNA treatment until starting differentiation. (Example: 12 hr
of mTeSR1 then 36 hr of BMP4, for a total of 48 hr). For endoderm, the first RPMI/Activin/CHIR-
99021 was immediately after siRNA, without a day of incubation in mTeSR1. After differentiation,
cells were fixed in 4% paraformaldehyde in PBS for 15 min at room temperature, washed with PBS,
and permeabalized with 5% BSA, PBS, 0.3% triton x-100 at 4˚C overnight. Next, cells were incubated
in primary antibody in 5% BSA, PBS, 0.3% triton x-100 at 4˚C overnight. Cells were washed with PBS
at room temperature, then incubated in secondary antibody in 5% BSA, PBS, 0.3% triton x-100 at
room temperature for 1 hr. Cells were washed with PBS, then incubated in 1 mg/mL DAPI in PBS for
10 min at room temperature, then washed with PBS. For Mesoderm (BMP4)the primary antibodies
were Oct4 (Millipore, Cat#MABD76) and Cdx2 rabbit (Abcam, Cat#ab76541), the secondary anti-
bodies were goat anti-mouse-Alexa 594, donkey anti-rabbit-Alexa 488. For endoderm the primary
antibody was Sox17 (R and D Systems, Cat#AF1924), the secondary antibody was donkey anti-goat-
Alexa 594 (Jackson ImmunoResearch). Cells were imaged in PBS on a Nikon Ti Eclipse inverted
microscope with an Andor Zyla 4.2 sCMOS detector. Images were taken as 3  3 scan of 20x fields
with a 0.75 NA objective, stitched with 15% overlap between fields using NIS-Elements Advanced
Research Software (Nikon, Japan). Shading correction was applied within the NIS-Elements software
before acquiring images. Raw images were quantified using a custom CellProfiler pipeline.
qPCR (Figure 3)
RNA lysates were prepared using Norgen Biotek’s Total RNA Purification Kit (Cat. 37500). Lysates
were first treated with Promega RQ1 RNase-Free DNase (Promega, Madison, WI), and then con-
verted to cDNA using Applied Biosystem’s High-Capacity RNA-to-cDNA Kit (Cat. 4387406). Quanti-
tative real-time PCR (qPCR) with SYBR Green (Bio-Rad; SsoAdvanced Universal SYBR Green
Supermix, Cat. 1725271) was carried out to assess gene expression. All results were normalized to
ACTB. Primers for qPCR were ordered from Eton Bioscience, San Diego, CA. Primers:
POU5F1-F: 5’-CCTGAAGCAGAAGAGGATCACC,
POU5F1-R 5’-AAAGCGGCAGATGGTCGTTTGG,
CDX2-F 5’-ACAGTCGCTACATCACCATCCG,
CDX2-R 5’-CCTCTCCTTTGCTCTGCGGTTC,
T-F 5’-CTTCAGCAAAGTCAAGCTCACC,
T-R 5’-TGAACTGGGTCTCAGGGAAGCA,
SOX17-F 5’-ACGCTTTCATGGTGTGGGCTAAG,
SOX17-R 5’-GTCAGCGCCTTCCACGACTTG,
CDT1-F 5’-GGAGGTCAGATTACCAGCTCAC,
CDT1-R, 5’-TTGACGTGCTCCACCAGCTTCT,
SOX2-F 5’-CTACAGCATGATGCAGGACCA,
SOX2 -R 5’-TCTGCGAGCTGGTCATGGAGT,
PAX6-F 5’-AATCAGAGAAGACAGGCCA,
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PAX6-R 5’-GTGTAGGTATCATAACTC,
ACTB-F 5’-CACCATTGGCAATGAGCGGTTC,
ACTB-R 5’-AGGTCTTTGCGGATGTCCACGT.
Generating ARPE-19-iPS cells
ARPE-19-iPS cells were derived from the human retinal pigment epithelial cell line ARPE-19 by
reprogramming with CytoTune-iPS 2.0 Sendai reprogramming kit (Invitrogen) following the manufac-
turer’s instructions.
Briefly, two days before Sendai virus transduction, 100,000 ARPE-19 cells were plated into one
well of a 6-well plate with ATCC-formulated DMEM:F12 medium and were transduced with the
CytoTune 2.0 Sendai reprogramming vectors at the MOI recommended by the manufacturer 48 hr
later (d0). The medium was replaced with fresh medium every other day starting from one day after
transduction (d1). At day 7, transduced cells were replated on Matrigel-coated six-well plates. Cells
were fed with Essential eight medium every day. Colonies started to form in 2–3 weeks and were
ready for transfer after an additional week. Undifferentiated colonies were manually picked and
transferred to Matrigel-coated six-well plates for expansion. After two rounds of subcloning and
expansion (after passage 10), RT-PCR was used to verify whether iPS cells were vector-free with the
primer sequences published in the manufacturer’s manual.
After iPS cells became virus-free, they were submitted to the University of Minnesota Cytoge-
nomic Laboratory for karyotype analysis. This analysis indicated that the ARPE-19-iPS cells have nor-
mal karyotypes.
Immunofluorescence characterization of ARPE-19-iPS cells
To examine pluripotency markers, iPS cells were fixed with 4% paraformaldehyde for 20 min. If
nuclear permeation was required, cells were treated with 0.2% triton-x-100 in phosphate-buffered
saline (PBS) for 30 min, blocked in 3% bovine serum albumin in PBS for 2 hr, and incubated with the
primary antibody overnight at 4˚C. Antibodies targeting the following antigens were used: TRA1-60
(MAB4360, 1:400), TRA1-81 (MAB4381, 1:400), stage-specific embryonic antigen-4 (MAB4304,
1:200), and stage- specific embryonic antigen-3 (MAB-4303, 1:200), all from Millipore/Chemicon (Bill-
erica, MA), OCT3/4 (AB27985, 1:200) from Abcam (Cambridge, MA), and NANOG (EB068601:100)
from Everest (Upper Heyford, Oxfordshire, UK). Cells were incubated with secondary Alexa Fluor
Series antibodies (all 1:500, Invitrogen) for 1 hr at room temperature and then with DAPI for 10 min.
Images were examined using an Olympus FluoView 1000 m IX81 inverted confocal microscope and
analyzed with Adobe Photoshop CS6. Direct alkaline phosphatase (AP) activity was analyzed as per
the manufacturer’s recommendations (Millipore).
Bisulfite sequencing and methylation analysis
Genomic DNA was isolated using the DNeasy Blood and Tissue kit (Qiagen, Germany) per manufac-
turer’s recommendations for isolation from mammalian cells. Bisulfite conversion was performed
using the Epitect Bisulfite kit (Qiagen) according to the manufacturer’s protocol for low amounts of
DNA. Single-step PCR amplification of the NANOG and OCT4 promoter regions were conducted
using Accuprime Supermix II (Invitrogen). Amplification products were visualized by gel electropho-
resis and bands were excised and purified using the QIAquick Gel Extraction kit (Qiagen). Purified
PCR products were inserted into the PCR4-TOPO vector (Invitrogen) and individual clones were
sequenced. Alignment and methylation analysis were performed using the online QUMA program
(http://quma.cdb.riken.jp/). Sequenced clones with at least 90% non-CpG cytosine conversion and at
least 90% sequence homology were retained for analysis.
Quantitative reverse transcriptase PCR (Figure 1—figure supplement 2)
RNA was isolated using RNeasy Mini kit (Qiagen) and treated with TURBO DNA-free (Ambion, Aus-
tin, TX). First-strand cDNA was synthesized using a Superscript III First-Strand Synthesis SuperMix
(Invitrogen). Reverse transcriptase-PCR was performed using TaqMan Gene Expression Assays and
TaqMan Universal PCR Master Mix, No AmpErase UNG (Applied Biosystems, Carslbad, CA) as per
the manufacturer’s protocol.
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TaqMan gene expression assays used were OCT4 (Hs04260367-gH), SOX2 (Hs01053049-sl),
NANOG (Hs04399610-g1), KLF4 (Hs00358836-m1), MYC (Hs00153408-m1), LIN28 (Hs00702808-s1),
REXO1 (Hs00810654-m1), ABCG2 (Hs1053790-m1), DNMT3 (Hs00171876-m1), with GAPDH
(Hs99999905-m1) used as an endogenous control. Expression levels were measured in duplicate. For
genes with expression below the fluorescence threshold, the cycle threshold (Ct) was set at 40 to cal-
culate the relative expression. Analysis was performed using an ABI PRISM 7500 sequence detection
system (Applied Biosystems).
Teratoma analysis
ARPE-19-iPS cells contained in a mixture of DMEM/F12, Matrigel and collagen were implanted onto
the hind flank of NSG mice (n = 5) until a palpable mass formed. Teratoma tissue was excised for his-
tological examination following embedding and staining by hematoxylin and eosin. Experiments
were conducted with the approval of the Institutional Animal Care and Research Committee at the
University of Minnesota.
Ergodic rate analysis
Ergodic Rate Analysis for cell cycle data was based on previously published work (Kafri et al.,
2013). First, the raw data from flow cytometry files were extracted using FCSExtract Utility (Earl F
Glynn) to comma separated value (.csv) files. The data in the .csv files were then gated in FCS
Express 6 (De Novo Software) and the data for only G1-MCMDNA were exported. MCM negative
cells were excluded based on the negative control sample (see Flow Cytometry). The mean MCM
loading rate was calculated in MATLAB (MathWorks). To calculate the mean MCM loading rate, the
G1-MCMDNA were subdivided into 10 equal sized bins, with rate calculated for each bin, and all 10
rates were averaged together for a mean MCM loading rate. The rate calculation was based on the
formula from Kafri et al:
wn ¼ a
2 F
fn
wn = MCM loading rate in bin n
a = ln(2)/doubling time (Figure 2—figure supplement 1)
F = number of G1-MCMDNAcells/total number of cells in sample. F was calculated from FCS
Express and entered into MATLAB manually (Figure 2—figure supplement 1).
fn = number of cells in bin n/number of G1-MCM
DNA cells
The bins were created in MATLAB (Figure 2—figure supplement 1). To control for small day to
day differences in raw data from staining intensities, the histogram edges were defined with the first
bin starting at the lowest MCM value and the last bin ending at the highest MCM value, divided into
10 equal sized bins between the lowest and highest MCM value. The 10 wn were then averaged for
a final mean w per sample. Sample MATLAB code:
alpha_iPSC = log(2)/15.64;
F_iPSC_1 = 0.0801;
%calculate lowest and highest MCM values%
maxMCM_iPSC_1 = max(iPSC_1(:,1));
minMCM_iPSC_1 = min(iPSC_1(:,1));
%create histogram with 10 bins and specified first and last bin limits%
h10_iPSC_1 = histogram(iPSC_1(:,1), 'NumBins', 10, 'BinLimits', [minMCM_iPSC_1, maxMCM_iPSC_1]);
%calculate fn within each bin%
totalf_iPSC_1 = size(iPSC_1);
fn10_iPSC_1=(h10_iPSC_1.Values)/totalf_iPSC_1(1,1);
%calculate mean w%
w10mean_iPSC_1 = mean(alpha_iPSC. *(2> F_iPSC_1)./fn10_iPSC_1);
The mean MCM loading rate was calculated for three biological replicates for each cell line, and
the replicates were averaged using GraphPad Prism for further statistical analysis. We cannot use
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ergodic rate analysis on actively differentiating cells (e.g. Figure 3) because they are not at steady
state.
Quantification and statistical analysis
Statistical analysis was performed with GraphPad Prism seven using unpaired, two-tailed t test (dis-
played as mean ±SD) or two-tailed Mann-Whitney test as indicated in figure legends. Significance
levels were set at *p0.05, **p0.01, ***p0.001, ****p0.0001. All experiments were performed a
minimum of two times, and representative data are shown in figures.
Acknowledgements
We are grateful to Ran Kafri for advice on ergodic rate analysis. We thank Jeffrey Jones for manage-
rial assistance, Dr. Sam Wolff for microscopy assistance, the UNC Human Pluripotent Stem Cell Core
stem cell culture assistance and A Adams, S Wong, M Consuegra, S Goraya, and S Sisk for technical
assistance. We also thank Dr. Robert Duronio, Dr. Michael Emanuele, and the Cook lab for helpful
discussions. We thank Ron McElmurry and Megan Riddle at the University of Minnesota for conduct-
ing teratoma assays, and the Cytogenomics Shared Resource (P30 CA077598) at the University of
Minnesota Masonic Cancer Center for karyotype analysis. The UNC Flow Cytometry Core Facility is
supported in part by P30 CA016086. This work was supported by a fellowship from the NSF (DGE-
1144081) to JPM and by grants from the NIH to JGC (GM083024 and GM102413), RMB (T32-
CA009138) JEP (DP2-HD091800) and AKB (GM074917). Additional funding was provided by the
WM Keck foundation to JEP and JGC; JT is supported by the Tulloch Chair in Stem Cell Biology,
Genetics and Genomics at the University of Minnesota.
Additional information
Funding
Funder Grant reference number Author
National Science Foundation Graduate Student Research
Fellowship DGE1144081
Jacob Peter Matson
National Institutes of Health Training Grant
T32CA009138
Ryan M Baxley
University of Minnesota Tulloch Chair in Stem Cell
Biology, Genetics and
Genomics
Jakub Tolar
National Institutes of Health Research Grant GM074917 Anja-Katrin Bielinsky
W. M. Keck Foundation Research Grant Jeremy E Purvis
Jeanette Gowen Cook
National Institutes of Health Research Grant
DP2HD091800
Jeremy E Purvis
National Institutes of Health Research Grant GM083024 Jeanette Gowen Cook
National Institutes of Health Research Grant GM102413 Jeanette Gowen Cook
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
Jacob Peter Matson, Conceptualization, Data curation, Formal analysis, Funding acquisition,
Validation, Investigation, Visualization, Methodology, Writing—original draft, Writing—review and
editing; Raluca Dumitru, Supervision, Investigation, Methodology; Philip Coryell, Ryan M Baxley, Kirk
Twaroski, Beau R Webber, Validation, Investigation, Visualization, Methodology; Weili Chen, Jakub
Tolar, Supervision, Validation, Investigation, Visualization, Methodology; Anja-Katrin Bielinsky,
Conceptualization, Resources, Supervision, Funding acquisition, Project administration, Writing—
review and editing; Jeremy E Purvis, Conceptualization, Resources, Software, Supervision, Funding
Matson et al. eLife 2017;6:e30473. DOI: https://doi.org/10.7554/eLife.30473 27 of 31
Research article Chromosomes and Gene Expression
acquisition, Writing—original draft, Project administration, Writing—review and editing; Jeanette
Gowen Cook, Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition,
Visualization, Writing—original draft, Project administration, Writing—review and editing
Author ORCIDs
Jacob Peter Matson http://orcid.org/0000-0002-9375-1676
Jakub Tolar http://orcid.org/0000-0002-0957-4380
Anja-Katrin Bielinsky https://orcid.org/0000-0003-1783-619X
Jeremy E Purvis http://orcid.org/0000-0002-6963-0524
Jeanette Gowen Cook https://orcid.org/0000-0003-0849-7405
Decision letter and Author response
Decision letter https://doi.org/10.7554/eLife.30473.024
Author response https://doi.org/10.7554/eLife.30473.025
Additional files
Supplementary files
. Transparent reporting form
DOI: https://doi.org/10.7554/eLife.30473.022
References
Arias EE, Walter JC. 2005. Replication-dependent destruction of Cdt1 limits DNA replication to a single round
per cell cycle in Xenopus egg extracts. Genes & Development 19:114–126. DOI: https://doi.org/10.1101/gad.
1255805, PMID: 15598982
Arias EE, Walter JC. 2007. Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic
cells. Genes & Development 21:497–518. DOI: https://doi.org/10.1101/gad.1508907, PMID: 17344412
Ballabeni A, Melixetian M, Zamponi R, Masiero L, Marinoni F, Helin K. 2004. Human geminin promotes pre-RC
formation and DNA replication by stabilizing CDT1 in mitosis. The EMBO Journal 23:3122–3132. DOI: https://
doi.org/10.1038/sj.emboj.7600314, PMID: 15257290
Ballabeni A, Park IH, Zhao R, Wang W, Lerou PH, Daley GQ, Kirschner MW. 2011. Cell cycle adaptations of
embryonic stem cells. PNAS 108:19252–19257. DOI: https://doi.org/10.1073/pnas.1116794108, PMID: 220840
91
Bernardo AS, Faial T, Gardner L, Niakan KK, Ortmann D, Senner CE, Callery EM, Trotter MW, Hemberger M,
Smith JC, Bardwell L, Moffett A, Pedersen RA. 2011. BRACHYURY and CDX2 mediate BMP-induced
differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages. Cell
Stem Cell 9:144–155. DOI: https://doi.org/10.1016/j.stem.2011.06.015, PMID: 21816365
Blow JJ, Ge XQ, Jackson DA. 2011. How dormant origins promote complete genome replication. Trends in
Biochemical Sciences 36:405–414. DOI: https://doi.org/10.1016/j.tibs.2011.05.002, PMID: 21641805
Bowers JL, Randell JC, Chen S, Bell SP. 2004. ATP hydrolysis by ORC catalyzes reiterative Mcm2-7 assembly at a
defined origin of replication. Molecular Cell 16:967–978. DOI: https://doi.org/10.1016/j.molcel.2004.11.038,
PMID: 15610739
Calder A, Roth-Albin I, Bhatia S, Pilquil C, Lee JH, Bhatia M, Levadoux-Martin M, McNicol J, Russell J, Collins T,
Draper JS. 2013. Lengthened G1 phase indicates differentiation status in human embryonic stem cells. Stem
Cells and Development 22:279–295. DOI: https://doi.org/10.1089/scd.2012.0168, PMID: 22827698
Carpenter AE, Jones TR, Lamprecht MR, Clarke C, Kang IH, Friman O, Guertin DA, Chang JH, Lindquist RA,
Moffat J, Golland P, Sabatini DM. 2006. CellProfiler: image analysis software for identifying and quantifying cell
phenotypes. Genome Biology 7:R100–R100.10. DOI: https://doi.org/10.1186/gb-2006-7-10-r100, PMID: 17076
895
Chandrasekaran S, Tan TX, Hall JR, Cook JG. 2011. Stress-stimulated mitogen-activated protein kinases control
the stability and activity of the Cdt1 DNA replication licensing factor. Molecular and Cellular Biology 31:4405–
4416. DOI: https://doi.org/10.1128/MCB.06163-11, PMID: 21930785
Chen T, Dent SY. 2014. Chromatin modifiers and remodellers: regulators of cellular differentiation. Nature
Reviews Genetics 15:93–106. DOI: https://doi.org/10.1038/nrg3607, PMID: 24366184
Choi SC, Choi JH, Park CY, Ahn CM, Hong SJ, Lim DS. 2012. Nanog regulates molecules involved in stemness
and cell cycle-signaling pathway for maintenance of pluripotency of P19 embryonal carcinoma stem cells.
Journal of Cellular Physiology 227:3678–3692. DOI: https://doi.org/10.1002/jcp.24076, PMID: 22378194
Clijsters L, Ogink J, Wolthuis R. 2013. The spindle checkpoint, APC/C(Cdc20), and APC/C(Cdh1) play distinct
roles in connecting mitosis to S phase. The Journal of Cell Biology 201:1013–1026. DOI: https://doi.org/10.
1083/jcb.201211019, PMID: 23775192
Matson et al. eLife 2017;6:e30473. DOI: https://doi.org/10.7554/eLife.30473 28 of 31
Research article Chromosomes and Gene Expression
Cocker JH, Piatti S, Santocanale C, Nasmyth K, Diffley JF. 1996. An essential role for the Cdc6 protein in forming
the pre-replicative complexes of budding yeast. Nature 379:180–182. DOI: https://doi.org/10.1038/379180a0,
PMID: 8538771
Coleman KE, Grant GD, Haggerty RA, Brantley K, Shibata E, Workman BD, Dutta A, Varma D, Purvis JE, Cook
JG. 2015. Sequential replication-coupled destruction at G1/S ensures genome stability. Genes & Development
29:1734–1746. DOI: https://doi.org/10.1101/gad.263731.115, PMID: 26272819
Cook JG, Park CH, Burke TW, Leone G, DeGregori J, Engel A, Nevins JR. 2002. Analysis of Cdc6 function in the
assembly of mammalian prereplication complexes. PNAS 99:1347–1352. DOI: https://doi.org/10.1073/pnas.
032677499, PMID: 11805305
Coronado D, Godet M, Bourillot PY, Tapponnier Y, Bernat A, Petit M, Afanassieff M, Markossian S, Malashicheva
A, Iacone R, Anastassiadis K, Savatier P. 2013. A short G1 phase is an intrinsic determinant of naı¨ve embryonic
stem cell pluripotency. Stem Cell Research 10:118–131. DOI: https://doi.org/10.1016/j.scr.2012.10.004,
PMID: 23178806
Deegan TD, Diffley JF. 2016. MCM: one ring to rule them all. Current Opinion in Structural Biology 37:145–151.
DOI: https://doi.org/10.1016/j.sbi.2016.01.014, PMID: 26866665
Dimitrova DS, Prokhorova TA, Blow JJ, Todorov IT, Gilbert DM. 2002. Mammalian nuclei become licensed for
DNA replication during late telophase. Journal of Cell Science 115:51–59. PMID: 11801723
Egozi D, Shapira M, Paor G, Ben-Izhak O, Skorecki K, Hershko DD. 2007. Regulation of the cell cycle inhibitor
p27 and its ubiquitin ligase Skp2 in differentiation of human embryonic stem cells. The FASEB Journal 21:2807–
2817. DOI: https://doi.org/10.1096/fj.06-7758com, PMID: 17475922
Ekholm-Reed S, Me´ndez J, Tedesco D, Zetterberg A, Stillman B, Reed SI. 2004. Deregulation of cyclin E in
human cells interferes with prereplication complex assembly. The Journal of Cell Biology 165:789–800.
DOI: https://doi.org/10.1083/jcb.200404092, PMID: 15197178
Evrin C, Clarke P, Zech J, Lurz R, Sun J, Uhle S, Li H, Stillman B, Speck C. 2009. A double-hexameric MCM2-7
complex is loaded onto origin DNA during licensing of eukaryotic DNA replication. PNAS 106:20240–20245.
DOI: https://doi.org/10.1073/pnas.0911500106, PMID: 19910535
Farrell JA, O’Farrell PH. 2014. From egg to gastrula: how the cell cycle is remodeled during the Drosophila mid-
blastula transition. Annual Review of Genetics 48:269–294. DOI: https://doi.org/10.1146/annurev-genet-
111212-133531, PMID: 25195504
Filipczyk AA, Laslett AL, Mummery C, Pera MF. 2007. Differentiation is coupled to changes in the cell cycle
regulatory apparatus of human embryonic stem cells. Stem Cell Research 1:45–60. DOI: https://doi.org/10.
1016/j.scr.2007.09.002, PMID: 19383386
Ge XQ, Jackson DA, Blow JJ. 2007. Dormant origins licensed by excess Mcm2-7 are required for human cells to
survive replicative stress. Genes & Development 21:3331–3341. DOI: https://doi.org/10.1101/gad.457807,
PMID: 18079179
Ge XQ, Blow JJ. 2009. The licensing checkpoint opens up. Cell Cycle 8:2320–2322. PMID: 19633410
Gonzales KA, Liang H, Lim YS, Chan YS, Yeo JC, Tan CP, Gao B, Le B, Tan ZY, Low KY, Liou YC, Bard F, Ng HH.
2015. Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways. Cell 162:564–579.
DOI: https://doi.org/10.1016/j.cell.2015.07.001, PMID: 26232226
Gray L, Griffeath D. 2001. The ergodic theory of traffic jams. Journal of Statistical Physics 105:413–452.
DOI: https://doi.org/10.1023/A:1012202706850
Ha˚land TW, Boye E, Stokke T, Grallert B, Syljua˚sen RG. 2015. Simultaneous measurement of passage through
the restriction point and MCM loading in single cells. Nucleic Acids Research 43:e150. DOI: https://doi.org/10.
1093/nar/gkv744, PMID: 26250117
Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA. 1992. Regulation of retinoblastoma protein
functions by ectopic expression of human cyclins. Cell 70:993–1006. DOI: https://doi.org/10.1016/0092-8674
(92)90249-C, PMID: 1388095
Ibarra A, Schwob E, Me´ndez J. 2008. Excess MCM proteins protect human cells from replicative stress by
licensing backup origins of replication. PNAS 105:8956–8961. DOI: https://doi.org/10.1073/pnas.0803978105,
PMID: 18579778
Kafri R, Levy J, Ginzberg MB, Oh S, Lahav G, Kirschner MW. 2013. Dynamics extracted from fixed cells reveal
feedback linking cell growth to cell cycle. Nature 494:480–483. DOI: https://doi.org/10.1038/nature11897,
PMID: 23446419
Kanai D, Ueda A, Akagi T, Yokota T, Koide H. 2015. Oct3/4 directly regulates expression of E2F3a in mouse
embryonic stem cells. Biochemical and Biophysical Research Communications 459:374–378. DOI: https://doi.
org/10.1016/j.bbrc.2015.02.105, PMID: 25727014
Kareta MS, Sage J, Wernig M. 2015a. Crosstalk between stem cell and cell cycle machineries. Current Opinion in
Cell Biology 37:68–74. DOI: https://doi.org/10.1016/j.ceb.2015.10.001, PMID: 26520682
Kareta MS, Gorges LL, Hafeez S, Benayoun BA, Marro S, Zmoos AF, Cecchini MJ, Spacek D, Batista LF, O’Brien
M, Ng YH, Ang CE, Vaka D, Artandi SE, Dick FA, Brunet A, Sage J, Wernig M. 2015b. Inhibition of pluripotency
networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis. Cell Stem Cell 16:39–50.
DOI: https://doi.org/10.1016/j.stem.2014.10.019, PMID: 25467916
Kermi C, Lo Furno E, Maiorano D. 2017. Regulation of DNA Replication in Early Embryonic Cleavages. Genes 8:
42. DOI: https://doi.org/10.3390/genes8010042, PMID: 28106858
Kimura H, Nozaki N, Sugimoto K. 1994. DNA polymerase alpha associated protein P1, a murine homolog of
yeast MCM3, changes its intranuclear distribution during the DNA synthetic period. The EMBO journal 13:
4311–4320. PMID: 7925275
Matson et al. eLife 2017;6:e30473. DOI: https://doi.org/10.7554/eLife.30473 29 of 31
Research article Chromosomes and Gene Expression
Kinjyo I, Qin J, Tan SY, Wellard CJ, Mrass P, Ritchie W, Doi A, Cavanagh LL, Tomura M, Sakaue-Sawano A,
Kanagawa O, Miyawaki A, Hodgkin PD, Weninger W. 2015. Real-time tracking of cell cycle progression during
CD8+ effector and memory T-cell differentiation. Nature Communications 6:6301. DOI: https://doi.org/10.
1038/ncomms7301, PMID: 25709008
Kuipers MA, Stasevich TJ, Sasaki T, Wilson KA, Hazelwood KL, McNally JG, Davidson MW, Gilbert DM. 2011.
Highly stable loading of Mcm proteins onto chromatin in living cells requires replication to unload. The Journal
of Cell Biology 192:29–41. DOI: https://doi.org/10.1083/jcb.201007111, PMID: 21220507
Lee J, Go Y, Kang I, Han YM, Kim J. 2010. Oct-4 controls cell-cycle progression of embryonic stem cells.
Biochemical Journal 426:171–181. DOI: https://doi.org/10.1042/BJ20091439, PMID: 19968627
Li H, Collado M, Villasante A, Matheu A, Lynch CJ, Can˜amero M, Rizzoti K, Carneiro C, Martı´nez G, Vidal A,
Lovell-Badge R, Serrano M. 2012. p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation.
Cell Stem Cell 11:845–852. DOI: https://doi.org/10.1016/j.stem.2012.09.014, PMID: 23217425
Liu L, Michowski W, Inuzuka H, Shimizu K, Nihira NT, Chick JM, Li N, Geng Y, Meng AY, Ordureau A,
Kołodziejczyk A, Ligon KL, Bronson RT, Polyak K, Harper JW, Gygi SP, Wei W, Sicinski P. 2017. G1 cyclins link
proliferation, pluripotency and differentiation of embryonic stem cells. Nature Cell Biology 19:177–188.
DOI: https://doi.org/10.1038/ncb3474, PMID: 28192421
Mailand N, Diffley JF. 2005. CDKs promote DNA replication origin licensing in human cells by protecting Cdc6
from APC/C-dependent proteolysis. Cell 122:915–926. DOI: https://doi.org/10.1016/j.cell.2005.08.013,
PMID: 16153703
McGarry TJ, Kirschner MW. 1998. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 93:
1043–1053. DOI: https://doi.org/10.1016/S0092-8674(00)81209-X, PMID: 9635433
McIntosh D, Blow JJ. 2012. Dormant origins, the licensing checkpoint, and the response to replicative stresses.
Cold Spring Harbor Perspectives in Biology 4:a012955. DOI: https://doi.org/10.1101/cshperspect.a012955,
PMID: 22904560
Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, Fang JE, Herschkowitz JI, Burrows AE, Ciccia A, Sun T, Schmitt
EM, Bernardi RJ, Fu X, Bland CS, Cooper TA, Schiff R, Rosen JM, Westbrook TF, Elledge SJ. 2011. The
pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proceedings of the National
Academy of Sciences 108:3665–3670. DOI: https://doi.org/10.1073/pnas.1019736108, PMID: 21307310
Me´ndez J, Stillman B. 2000. Chromatin association of human origin recognition complex, cdc6, and
minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late
mitosis. Molecular and Cellular Biology 20:8602–8612. DOI: https://doi.org/10.1128/MCB.20.22.8602-8612.
2000, PMID: 11046155
Moreno A, Carrington JT, Albergante L, Al Mamun M, Haagensen EJ, Komseli ES, Gorgoulis VG, Newman TJ,
Blow JJ. 2016. Unreplicated DNA remaining from unperturbed S phases passes through mitosis for resolution
in daughter cells. PNAS 113:E5757–E5764. DOI: https://doi.org/10.1073/pnas.1603252113, PMID: 27516545
Neganova I, Zhang X, Atkinson S, Lako M. 2009. Expression and functional analysis of G1 to S regulatory
components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells.
Oncogene 28:20–30. DOI: https://doi.org/10.1038/onc.2008.358, PMID: 18806832
Nevis KR, Cordeiro-Stone M, Cook JG. 2009. Origin licensing and p53 status regulate Cdk2 activity during G(1).
Cell Cycle 8:1952–1963. DOI: https://doi.org/10.4161/cc.8.12.8811, PMID: 19440053
Nishitani H, Lygerou Z, Nishimoto T, Nurse P. 2000. The Cdt1 protein is required to license DNA for replication
in fission yeast. Nature 404:625–628. DOI: https://doi.org/10.1038/35007110, PMID: 10766248
Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, Yagi R, Rossant J. 2005. Interaction between Oct3/4
and Cdx2 determines trophectoderm differentiation. Cell 123:917–929. DOI: https://doi.org/10.1016/j.cell.
2005.08.040, PMID: 16325584
O’Farrell PH, Stumpff J, Tin Su T, Su TT. 2004. Embryonic cleavage cycles: How is a mouse like a fly? Current
Biology 14:R35–R45. DOI: https://doi.org/10.1016/j.cub.2003.12.022
Pauklin S, Madrigal P, Bertero A, Vallier L. 2016. Initiation of stem cell differentiation involves cell cycle-
dependent regulation of developmental genes by Cyclin D. Genes & Development 30:421–433. DOI: https://
doi.org/10.1101/gad.271452.115, PMID: 26883361
Pauklin S, Vallier L. 2013. The cell-cycle state of stem cells determines cell fate propensity. Cell 155:135–147.
DOI: https://doi.org/10.1016/j.cell.2013.08.031, PMID: 24074866
Petersen BO, Wagener C, Marinoni F, Kramer ER, Melixetian M, Lazzerini Denchi E, Gieffers C, Matteucci C,
Peters JM, Helin K. 2000. Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent
on APC-CDH1. Genes & Development 14:2330–2343. DOI: https://doi.org/10.1101/gad.832500, PMID: 109953
89
Pozo P, Cook J. 2016. Regulation and function of cdt1; a key factor in cell proliferation and genome stability.
Genes 8:2. DOI: https://doi.org/10.3390/genes8010002
Pruitt SC, Bailey KJ, Freeland A. 2007. Reduced Mcm2 expression results in severe stem/progenitor cell
deficiency and cancer. Stem Cells 25:3121–3132. DOI: https://doi.org/10.1634/stemcells.2007-0483,
PMID: 17717065
Randell JC, Bowers JL, Rodrı´guez HK, Bell SP. 2006. Sequential ATP hydrolysis by Cdc6 and ORC directs loading
of the Mcm2-7 helicase. Molecular Cell 21:29–39. DOI: https://doi.org/10.1016/j.molcel.2005.11.023,
PMID: 16387651
Remus D, Beuron F, Tolun G, Griffith JD, Morris EP, Diffley JF. 2009. Concerted loading of Mcm2-7 double
hexamers around DNA during DNA replication origin licensing. Cell 139:719–730. DOI: https://doi.org/10.
1016/j.cell.2009.10.015, PMID: 19896182
Matson et al. eLife 2017;6:e30473. DOI: https://doi.org/10.7554/eLife.30473 30 of 31
Research article Chromosomes and Gene Expression
Remus D, Diffley JF. 2009. Eukaryotic DNA replication control: lock and load, then fire. Current Opinion in Cell
Biology 21:771–777. DOI: https://doi.org/10.1016/j.ceb.2009.08.002, PMID: 19767190
Resnitzky D, Gossen M, Bujard H, Reed SI. 1994. Acceleration of the G1/S phase transition by expression of
cyclins D1 and E with an inducible system. Molecular and Cellular Biology 14:1669–1679. DOI: https://doi.org/
10.1128/MCB.14.3.1669, PMID: 8114703
Rizzardi LF, Coleman KE, Varma D, Matson JP, Oh S, Cook JG. 2015. CDK1-dependent inhibition of the E3
ubiquitin ligase CRL4CDT2 ensures robust transition from S Phase to Mitosis. Journal of Biological Chemistry
290:556–567. DOI: https://doi.org/10.1074/jbc.M114.614701, PMID: 25411249
Robinson M, Chapani P, Styan T, Vaidyanathan R, Willerth SM. 2016. Functionalizing ascl1 with novel intracellular
protein delivery technology for promoting neuronal differentiation of human induced pluripotent stem cells.
Stem Cell Reviews and Reports 12:476–483. DOI: https://doi.org/10.1007/s12015-016-9655-7, PMID: 27138845
Scognamiglio R, Cabezas-Wallscheid N, Thier MC, Altamura S, Reyes A, Prendergast A´M, Baumga¨rtner D,
Carnevalli LS, Atzberger A, Haas S, von Paleske L, Boroviak T, Wo¨rsdo¨rfer P, Essers MA, Kloz U, Eisenman RN,
Edenhofer F, Bertone P, Huber W, van der Hoeven F, et al. 2016. Myc depletion induces a pluripotent dormant
state mimicking diapause. Cell 164:668–680. DOI: https://doi.org/10.1016/j.cell.2015.12.033, PMID: 26871632
Sela Y, Molotski N, Golan S, Itskovitz-Eldor J, Soen Y. 2012. Human embryonic stem cells exhibit increased
propensity to differentiate during the G1 phase prior to phosphorylation of retinoblastoma protein. Stem Cells
30:1097–1108. DOI: https://doi.org/10.1002/stem.1078, PMID: 22415928
Shima N, Alcaraz A, Liachko I, Buske TR, Andrews CA, Munroe RJ, Hartford SA, Tye BK, Schimenti JC. 2007. A
viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice. Nature Genetics
39:93–98. DOI: https://doi.org/10.1038/ng1936, PMID: 17143284
Shreeram S, Sparks A, Lane DP, Blow JJ. 2002. Cell type-specific responses of human cells to inhibition of
replication licensing. Oncogene 21:6624–6632. DOI: https://doi.org/10.1038/sj.onc.1205910, PMID: 12242660
Siddiqui K, On KF, Diffley JF. 2013. Regulating DNA replication in eukarya. Cold Spring Harbor Perspectives in
Biology 5:a012930. DOI: https://doi.org/10.1101/cshperspect.a012930, PMID: 23838438
Soufi A, Dalton S. 2016. Cycling through developmental decisions: how cell cycle dynamics control pluripotency,
differentiation and reprogramming. Development 143:4301–4311. DOI: https://doi.org/10.1242/dev.142075,
PMID: 27899507
Sugimoto N, Tatsumi Y, Tsurumi T, Matsukage A, Kiyono T, Nishitani H, Fujita M. 2004. Cdt1 phosphorylation by
cyclin A-dependent kinases negatively regulates its function without affecting geminin binding. Journal of
Biological Chemistry 279:19691–19697. DOI: https://doi.org/10.1074/jbc.M313175200, PMID: 14993212
Symeonidou IE, Kotsantis P, Roukos V, Rapsomaniki MA, Grecco HE, Bastiaens P, Taraviras S, Lygerou Z. 2013.
Multi-step loading of human minichromosome maintenance proteins in live human cells. Journal of Biological
Chemistry 288:35852–35867. DOI: https://doi.org/10.1074/jbc.M113.474825, PMID: 24158436
Tanaka S, Diffley JF. 2002. Deregulated G1-cyclin expression induces genomic instability by preventing efficient
pre-RC formation. Genes & Development 16:2639–2649. DOI: https://doi.org/10.1101/gad.1011002,
PMID: 12381663
Teer JK, Machida YJ, Labit H, Novac O, Hyrien O, Marheineke K, Zannis-Hadjopoulos M, Dutta A. 2006.
Proliferating human cells hypomorphic for origin recognition complex 2 and pre-replicative complex formation
have a defect in p53 activation and Cdk2 kinase activation. Journal of Biological Chemistry 281:6253–6260.
DOI: https://doi.org/10.1074/jbc.M507150200, PMID: 16407251
Ticau S, Friedman LJ, Ivica NA, Gelles J, Bell SP. 2015. Single-molecule studies of origin licensing reveal
mechanisms ensuring bidirectional helicase loading. Cell 161:513–525. DOI: https://doi.org/10.1016/j.cell.2015.
03.012, PMID: 25892223
Todorov IT, Attaran A, Kearsey SE. 1995. BM28, a human member of the MCM2-3-5 family, is displaced from
chromatin during DNA replication. The Journal of Cell Biology 129:1433–1445. DOI: https://doi.org/10.1083/
jcb.129.6.1433, PMID: 7790346
Truong LN, Wu X. 2011. Prevention of DNA re-replication in eukaryotic cells. Journal of Molecular Cell Biology 3:
13–22. DOI: https://doi.org/10.1093/jmcb/mjq052, PMID: 21278447
Tsunematsu T, Takihara Y, Ishimaru N, PaganoM, Takata T, Kudo Y. 2013. Aurora-A controls pre-replicative
complex assembly and DNA replication by stabilizing geminin in mitosis.Nature Communications 4:1–11.
DOI: https://doi.org/10.1038/ncomms2859
Varma D, Chandrasekaran S, Sundin LJ, Reidy KT, Wan X, Chasse DA, Nevis KR, DeLuca JG, Salmon ED, Cook
JG. 2012. Recruitment of the human Cdt1 replication licensing protein by the loop domain of Hec1 is required
for stable kinetochore-microtubule attachment. Nature Cell Biology 14:593–603. DOI: https://doi.org/10.1038/
ncb2489, PMID: 22581055
Watanabe K, Ueno M, Kamiya D, Nishiyama A, Matsumura M, Wataya T, Takahashi JB, Nishikawa S, Nishikawa S,
Muguruma K, Sasai Y. 2007. A ROCK inhibitor permits survival of dissociated human embryonic stem cells.
Nature Biotechnology 25:681–686. DOI: https://doi.org/10.1038/nbt1310, PMID: 17529971
Woodward AM, Go¨hler T, Luciani MG, Oehlmann M, Ge X, Gartner A, Jackson DA, Blow JJ. 2006. Excess
Mcm2-7 license dormant origins of replication that can be used under conditions of replicative stress. The
Journal of Cell Biology 173:673–683. DOI: https://doi.org/10.1083/jcb.200602108, PMID: 16754955
Matson et al. eLife 2017;6:e30473. DOI: https://doi.org/10.7554/eLife.30473 31 of 31
Research article Chromosomes and Gene Expression
